{"status": "ok", "message-type": "work-list", "message-version": "1.0.0", "message": {"facets": {}, "total-results": 110687, "items": [{"indexed": {"date-parts": [[2019, 11, 23]], "date-time": "2019-11-23T05:30:58Z", "timestamp": 1574487058931}, "reference-count": 68, "publisher": "Elsevier BV", "issue": "2", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2011, 1, 1]], "date-time": "2011-01-01T00:00:00Z", "timestamp": 1293840000000}, "delay-in-days": 0, "content-version": "tdm"}, {"URL": "https://www.elsevier.com/open-access/userlicense/1.0/", "start": {"date-parts": [[2013, 8, 22]], "date-time": "2013-08-22T00:00:00Z", "timestamp": 1377129600000}, "delay-in-days": 964, "content-version": "vor"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Molecular Cell"], "published-print": {"date-parts": [[2011, 1]]}, "DOI": "10.1016/j.molcel.2010.12.005", "type": "journal-article", "created": {"date-parts": [[2010, 12, 31]], "date-time": "2010-12-31T09:48:08Z", "timestamp": 1293788888000}, "page": "210-220", "source": "Crossref", "is-referenced-by-count": 246, "title": ["miR-182-Mediated Downregulation of BRCA1 Impacts DNA Repair and Sensitivity to PARP Inhibitors"], "prefix": "10.1016", "volume": "41", "author": [{"given": "Patryk", "family": "Moskwa", "sequence": "first", "affiliation": []}, {"given": "Francesca M.", "family": "Buffa", "sequence": "additional", "affiliation": []}, {"given": "Yunfeng", "family": "Pan", "sequence": "additional", "affiliation": []}, {"given": "Rohit", "family": "Panchakshari", "sequence": "additional", "affiliation": []}, {"given": "Ponnari", "family": "Gottipati", "sequence": "additional", "affiliation": []}, {"given": "Ruth J.", "family": "Muschel", "sequence": "additional", "affiliation": []}, {"given": "John", "family": "Beech", "sequence": "additional", "affiliation": []}, {"given": "Ritu", "family": "Kulshrestha", "sequence": "additional", "affiliation": []}, {"given": "Kotb", "family": "Abdelmohsen", "sequence": "additional", "affiliation": []}, {"given": "David M.", "family": "Weinstock", "sequence": "additional", "affiliation": []}, {"given": "Myriam", "family": "Gorospe", "sequence": "additional", "affiliation": []}, {"given": "Adrian L.", "family": "Harris", "sequence": "additional", "affiliation": []}, {"given": "Thomas", "family": "Helleday", "sequence": "additional", "affiliation": []}, {"given": "Dipanjan", "family": "Chowdhury", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Molecular Cell"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S1097276510009615?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S1097276510009615?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2018, 12, 5]], "date-time": "2018-12-05T21:23:07Z", "timestamp": 1544044987000}, "score": 61.594543, "issued": {"date-parts": [[2011, 1]]}, "references-count": 68, "journal-issue": {"published-print": {"date-parts": [[2011, 1]]}, "issue": "2"}, "alternative-id": ["S1097276510009615"], "URL": "http://dx.doi.org/10.1016/j.molcel.2010.12.005", "ISSN": ["1097-2765"], "issn-type": [{"value": "1097-2765", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 12, 4]], "date-time": "2019-12-04T01:41:10Z", "timestamp": 1575423670609}, "update-to": [{"updated": {"date-parts": [[2014, 1, 9]], "date-time": "2014-01-09T00:00:00Z", "timestamp": 1389225600000}, "DOI": "10.1016/j.molcel.2010.12.005", "type": "erratum", "label": "Erratum"}], "reference-count": 0, "publisher": "Elsevier BV", "issue": "1", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2014, 1, 1]], "date-time": "2014-01-01T00:00:00Z", "timestamp": 1388534400000}, "delay-in-days": 0, "content-version": "tdm"}, {"URL": "http://www.elsevier.com/open-access/userlicense/1.0/", "start": {"date-parts": [[2015, 1, 9]], "date-time": "2015-01-09T00:00:00Z", "timestamp": 1420761600000}, "delay-in-days": 373, "content-version": "vor"}], "content-domain": {"domain": ["cell.com", "elsevier.com", "sciencedirect.com"], "crossmark-restriction": true}, "short-container-title": ["Molecular Cell"], "published-print": {"date-parts": [[2014, 1]]}, "DOI": "10.1016/j.molcel.2013.12.015", "type": "journal-article", "created": {"date-parts": [[2014, 1, 9]], "date-time": "2014-01-09T15:18:29Z", "timestamp": 1389280709000}, "page": "162-163", "update-policy": "http://dx.doi.org/10.1016/elsevier_cm_policy", "source": "Crossref", "is-referenced-by-count": 2, "title": ["miR-182-Mediated Downregulation of BRCA1 Impacts DNA Repair and Sensitivity to PARP Inhibitors"], "prefix": "10.1016", "volume": "53", "author": [{"given": "Patryk", "family": "Moskwa", "sequence": "first", "affiliation": []}, {"given": "Francesca\u00a0M.", "family": "Buffa", "sequence": "additional", "affiliation": []}, {"given": "Yunfeng", "family": "Pan", "sequence": "additional", "affiliation": []}, {"given": "Rohit", "family": "Panchakshari", "sequence": "additional", "affiliation": []}, {"given": "Ponnari", "family": "Gottipati", "sequence": "additional", "affiliation": []}, {"given": "Ruth\u00a0J.", "family": "Muschel", "sequence": "additional", "affiliation": []}, {"given": "John", "family": "Beech", "sequence": "additional", "affiliation": []}, {"given": "Ritu", "family": "Kulshrestha", "sequence": "additional", "affiliation": []}, {"given": "Kotb", "family": "Abdelmohsen", "sequence": "additional", "affiliation": []}, {"given": "David\u00a0M.", "family": "Weinstock", "sequence": "additional", "affiliation": []}, {"given": "Myriam", "family": "Gorospe", "sequence": "additional", "affiliation": []}, {"given": "Adrian\u00a0L.", "family": "Harris", "sequence": "additional", "affiliation": []}, {"given": "Thomas", "family": "Helleday", "sequence": "additional", "affiliation": []}, {"given": "Dipanjan", "family": "Chowdhury", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Molecular Cell"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S1097276513009258?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S1097276513009258?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 5, 8]], "date-time": "2019-05-08T21:44:35Z", "timestamp": 1557351875000}, "score": 61.594543, "issued": {"date-parts": [[2014, 1]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2014, 1]]}, "issue": "1"}, "alternative-id": ["S1097276513009258"], "URL": "http://dx.doi.org/10.1016/j.molcel.2013.12.015", "ISSN": ["1097-2765"], "issn-type": [{"value": "1097-2765", "type": "print"}], "subject": ["Cell Biology", "Molecular Biology"], "assertion": [{"value": "Elsevier", "name": "publisher", "label": "This article is maintained by"}, {"value": "miR-182-Mediated Downregulation of BRCA1 Impacts DNA Repair and Sensitivity to PARP Inhibitors", "name": "articletitle", "label": "Article Title"}, {"value": "Molecular Cell", "name": "journaltitle", "label": "Journal Title"}, {"value": "https://doi.org/10.1016/j.molcel.2013.12.015", "name": "articlelink", "label": "CrossRef DOI link to publisher maintained version"}, {"value": "https://doi.org/10.1016/j.molcel.2010.12.005", "name": "associatedlink", "label": "CrossRef DOI link to the associated document"}, {"value": "simple-article", "name": "content_type", "label": "Content Type"}, {"value": "Copyright \u00a9 2014 Elsevier Inc. All rights reserved.", "name": "copyright", "label": "Copyright"}]}, {"indexed": {"date-parts": [[2019, 12, 4]], "date-time": "2019-12-04T12:03:16Z", "timestamp": 1575460996900}, "reference-count": 0, "publisher": "American Association for Cancer Research (AACR)", "issue": "6", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Molecular Cancer Therapeutics"], "published-print": {"date-parts": [[2014, 6, 1]]}, "DOI": "10.1158/1535-7163.mct-13-0906-t", "type": "journal-article", "created": {"date-parts": [[2014, 4, 3]], "date-time": "2014-04-03T06:51:09Z", "timestamp": 1396507869000}, "page": "1645-1654", "source": "Crossref", "is-referenced-by-count": 32, "title": ["New Insights into PARP Inhibitors' Effect on Cell Cycle and Homology-Directed DNA Damage Repair"], "prefix": "10.1158", "volume": "13", "author": [{"given": "P.", "family": "Jelinic", "sequence": "first", "affiliation": []}, {"given": "D. A.", "family": "Levine", "sequence": "additional", "affiliation": []}], "member": "1086", "published-online": {"date-parts": [[2014, 4, 2]]}, "container-title": ["Molecular Cancer Therapeutics"], "language": "en", "link": [{"URL": "https://syndication.highwire.org/content/doi/10.1158/1535-7163.MCT-13-0906-T", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2016, 12, 23]], "date-time": "2016-12-23T08:06:06Z", "timestamp": 1482480366000}, "score": 29.125584, "issued": {"date-parts": [[2014, 4, 2]]}, "references-count": 0, "journal-issue": {"published-online": {"date-parts": [[2014, 6, 4]]}, "published-print": {"date-parts": [[2014, 6, 1]]}, "issue": "6"}, "URL": "http://dx.doi.org/10.1158/1535-7163.mct-13-0906-t", "ISSN": ["1535-7163", "1538-8514"], "issn-type": [{"value": "1535-7163", "type": "print"}, {"value": "1538-8514", "type": "electronic"}], "subject": ["Cancer Research", "Oncology"]}, {"indexed": {"date-parts": [[2019, 11, 25]], "date-time": "2019-11-25T15:31:21Z", "timestamp": 1574695881556}, "reference-count": 104, "publisher": "Elsevier", "isbn-type": [{"value": "9780128033098", "type": "print"}], "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2016, 1, 1]], "date-time": "2016-01-01T00:00:00Z", "timestamp": 1451606400000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[2016]]}, "DOI": "10.1016/b978-0-12-803309-8.00019-7", "type": "book-chapter", "created": {"date-parts": [[2016, 9, 9]], "date-time": "2016-09-09T19:26:37Z", "timestamp": 1473449197000}, "page": "321-336", "source": "Crossref", "is-referenced-by-count": 1, "title": ["Repair of Double-Strand Breaks by Nonhomologous End Joining"], "prefix": "10.1016", "author": [{"given": "P.", "family": "Moskwa", "sequence": "first", "affiliation": []}], "member": "78", "container-title": ["Genome Stability"], "link": [{"URL": "https://api.elsevier.com/content/article/PII:B9780128033098000197?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:B9780128033098000197?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 9, 13]], "date-time": "2019-09-13T10:03:31Z", "timestamp": 1568369011000}, "score": 29.092857, "issued": {"date-parts": [[2016]]}, "ISBN": ["9780128033098"], "references-count": 104, "URL": "http://dx.doi.org/10.1016/b978-0-12-803309-8.00019-7"}, {"indexed": {"date-parts": [[2019, 12, 2]], "date-time": "2019-12-02T10:32:59Z", "timestamp": 1575282779525}, "reference-count": 44, "publisher": "Walter de Gruyter GmbH", "issue": "1", "license": [{"URL": "http://creativecommons.org/licenses/by-nc-nd/4.0", "start": {"date-parts": [[2018, 3, 1]], "date-time": "2018-03-01T00:00:00Z", "timestamp": 1519862400000}, "delay-in-days": 0, "content-version": "unspecified"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[2018, 3, 1]]}, "abstract": "<jats:title>Abstract</jats:title><jats:p>The DNA repair process protects the cells from DNA damaging agent by multiple pathways. Majority of the cancer therapy cause DNA damage which leads to apoptosis. The cell has natural ability to repair this damage which ultimately leads to development of resistance of drugs. The key enzymes involved in DNA repair process are poly(ADP-ribose) (PAR) and poly(ADP-ribose) polymerases (PARP). Tumor cells repair their defective gene via defective homologues recombination (HR) in the presence of enzyme PARP. PARP inhibitors inhibit the enzyme poly(ADP-ribose) polymerases (PARPs) which lead to apoptosis of cancer cells. Current clinical data shows the role of PARP inhibitors is not restricted to BRCA mutations but also effective in HR dysfunctions related tumors. Therefore, investigation in this area could be very helpful for future therapy of cancer. This review gives detail information on the role of PARP in DNA damage repair, the role of PARP inhibitors and chemistry of currently available PARP inhibitors.</jats:p>", "DOI": "10.1515/folmed-2017-0067", "type": "journal-article", "created": {"date-parts": [[2018, 4, 18]], "date-time": "2018-04-18T22:16:03Z", "timestamp": 1524089763000}, "page": "39-47", "source": "Crossref", "is-referenced-by-count": 3, "title": ["A Review on DNA Repair Inhibition by PARP Inhibitors in Cancer Therapy"], "prefix": "10.1515", "volume": "60", "author": [{"given": "Ashish P.", "family": "Shah", "sequence": "first", "affiliation": []}, {"given": "Chhagan N.", "family": "Patel", "sequence": "additional", "affiliation": []}, {"given": "Dipen K.", "family": "Sureja", "sequence": "additional", "affiliation": []}, {"given": "Kirtan P.", "family": "Sanghavi", "sequence": "additional", "affiliation": []}], "member": "374", "reference": [{"key": "ref21", "first-page": "1", "article-title": "ME Prolonged poly ribose polymerase activity regulates induced sustained cytokine expression in alveolar macrophages Free", "volume": "8", "author": "Espinoza LA", "year": "2007", "journal-title": "Biol Med"}, {"key": "ref251", "first-page": "7481", "article-title": "Structure of the catalytic fragment of poly ( AD - ribose ) polymerase from chicken Proceedings of the National Academy of", "volume": "26", "author": "Ruf", "year": "1996", "journal-title": "Sciences"}, {"key": "ref331", "author": "Tutt", "year": "2009", "article-title": "Phase II trial of the oral PARP inhibitor olaparib in BRCA - deficient advanced breast cancer Annual Meeting Proceedings"}, {"key": "ref191", "doi-asserted-by": "crossref", "first-page": "1", "DOI": "10.1093/emboj/20.13.3535", "article-title": "Loss of poly ribose polymerase causes increased tumour latency in deficient mice", "volume": "20", "author": "Conde", "year": "2001", "journal-title": "EMBO J"}, {"key": "ref31", "doi-asserted-by": "crossref", "first-page": "1", "DOI": "10.1016/j.cellsig.2007.10.007", "article-title": "AS Nuclear translocation of \u03baB is sufficient for but not expression in TNF - stimulated smooth muscle cells : Differential requirement for expression and interaction", "volume": "20", "author": "Zerfaoui", "year": "2008", "journal-title": "Cell Signal"}, {"key": "ref171", "first-page": "18", "article-title": "ribosyl ation accelerates DNA repair in a pathway dependent on Cockayne syndrome protein", "volume": "18", "author": "Flohr", "year": "2003", "journal-title": "Poly Nucleic Acids Res"}, {"key": "ref491", "author": "Kristeleit", "first-page": "1", "year": "2014", "article-title": "Phase study of oral rucaparib Final phase results Meeting", "journal-title": "Annual Proceedings"}, {"key": "ref51", "first-page": "66", "article-title": "SH of inhibitors an unfinished story", "volume": "24", "author": "Patel", "year": "2010", "journal-title": "Development Oncology"}, {"key": "ref381", "author": "Mahany", "first-page": "39", "year": "2008", "article-title": "phase IB study evaluating BSI in combination with chemotherapy in subjects with advanced solid tumors Annual Meeting Proceedings"}, {"key": "ref241", "doi-asserted-by": "crossref", "first-page": "2255", "DOI": "10.1093/emboj/cdg206", "article-title": "de Functional interaction between in chromosome stability and embryonic development in mouse", "volume": "25", "author": "Murcia", "year": "2003", "journal-title": "EMBO J"}, {"key": "ref411", "author": "Tutt", "first-page": "376", "year": "2010", "article-title": "Oral poly ribose ) polymerase inhibitor olaparib in patients with or mutations and advanced breast cancer : a proof - of - concept trial", "journal-title": "Lancet"}, {"key": "ref41", "first-page": "434", "article-title": "Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy", "volume": "21", "author": "Farmer", "year": "2005", "journal-title": "Nature"}, {"key": "ref181", "first-page": "1", "article-title": "ri polymerase plays a role in suppressing mammary tumourigenesis in mice", "volume": "19", "author": "Tong", "year": "2007", "journal-title": "Poly Oncogene"}, {"key": "ref371", "first-page": "014699", "article-title": "Phase study of the poly ribose polymerase inhibitor in combination with temozolomide in patients with advanced solid tumors", "volume": "14", "author": "Plummer", "year": "2008", "journal-title": "Clin Cancer Res"}, {"key": "ref421", "author": "Kaufman", "volume": "33", "first-page": "1", "article-title": "Olaparib monotherapy in patients with advanced cancer and a germline mutation", "journal-title": "J Clin Oncol"}, {"key": "ref441", "doi-asserted-by": "crossref", "first-page": "372", "DOI": "10.1200/JCO.2011.36.9215", "article-title": "Phase II open - label randomized multicenter study comparing the efficacy and safety of olaparib a poly ribose ) polymerase inhibitor and pegylated liposomal doxorubicin in patients with or mutations and recurrent ovarian cancer", "volume": "30", "author": "Kaye", "year": "2012", "journal-title": "J Clin Oncol"}, {"key": "ref481", "doi-asserted-by": "crossref", "first-page": "49", "DOI": "10.1016/S1470-2045(13)70240-7", "article-title": "The poly ribose polymerase inhibitor niraparib in BRCA mutation carriers and patients with sporadic cancer : a phase dose - escalation trial", "volume": "14", "author": "Sandhu", "year": "2013", "journal-title": "Lancet Oncol"}, {"key": "ref261", "first-page": "107", "article-title": "Dihydroisoquinolinones the design and synthesis of a new series of potent inhibitors of poly ribose polymerase Anticancer Des", "volume": "27", "author": "Suto", "year": "1991", "journal-title": "Drug"}, {"key": "ref391", "doi-asserted-by": "crossref", "first-page": "1001", "DOI": "10.1080/07357900802709159", "article-title": "AY NE KB phase IB trial of intravenous INO plus oral temozolomide in subjects with unresectable stage - III or IV melanoma", "volume": "27", "author": "Bedikian", "year": "2009", "journal-title": "Cancer Invest"}, {"key": "ref301", "doi-asserted-by": "crossref", "first-page": "488", "DOI": "10.1016/j.bmcl.2009.11.127", "article-title": "Synthesis and biological evaluation of substituted phenyl indazole carboxamides as potent poly ribose polymerase inhibitors", "volume": "31", "author": "Scarpelli", "year": "2010", "journal-title": "Bioorg Med Chem Lett"}, {"key": "ref281", "first-page": "1", "article-title": "Discovery of propylpiperidin yl benzimidazole carboxamide a potent inhibitor of poly ribose polymerase for the treatment of cancer", "volume": "29", "author": "Penning", "year": "2008", "journal-title": "Med Chem"}, {"key": "ref61", "first-page": "1", "article-title": "Synthetic lethal targeting of PTEN mutant cells with PARP inhibitors", "volume": "22", "author": "Mendes", "year": "2009", "journal-title": "AM Mol Med"}, {"key": "ref321", "author": "Abdullah", "volume": "23", "first-page": "1", "article-title": "Benzimidazole derivatives as potential dual inhibitors for", "journal-title": "Med Chem"}, {"key": "ref111", "first-page": "411", "article-title": "maintenance mechanisms for preventing cancer", "volume": "12", "author": "Hoeijmakers", "year": "2001", "journal-title": "Genome Nature"}, {"key": "ref231", "doi-asserted-by": "crossref", "first-page": "363", "DOI": "10.1016/j.coph.2008.06.016", "article-title": "Targeted therapy for cancer using PARP inhibitors", "volume": "24", "author": "Lord", "year": "2008", "journal-title": "Curr Opin Pharmacol"}, {"key": "ref201", "doi-asserted-by": "crossref", "first-page": "2109", "DOI": "10.1002/j.1460-2075.1993.tb05859.x", "article-title": "Overproduction of the poly ribose ) polymerase DNA - binding domain blocks alkylation - induced DNA repair synthesis in mammalian cells", "volume": "21", "author": "Molinete", "year": "1993", "journal-title": "EMBO J"}, {"key": "ref431", "doi-asserted-by": "crossref", "first-page": "852", "DOI": "10.1016/S1470-2045(11)70214-5", "article-title": "Olaparib in patients with recurrent high - grade serous or poorly differentiated ovarian carcinoma or triple - negative breast cancer : a phase multicentre open label non - randomised study", "volume": "12", "author": "Gelmon", "year": "2011", "journal-title": "Lancet Oncol"}, {"key": "ref141", "first-page": "1", "article-title": "requirement for for the assembly or stability of nuclear foci at sites of oxidative DNA damage", "volume": "15", "author": "Khamisy", "year": "2003", "journal-title": "Nucleic Acids Res"}, {"key": "ref351", "doi-asserted-by": "crossref", "first-page": "4827", "DOI": "10.1021/jm901188v", "article-title": "Discovery of Piperidin yl phenyl indazole carboxamide a novel oral poly ribose polymerase inhibitor efficacious in BRCA and mutant tumors", "volume": "52", "author": "Jones", "year": "2009", "journal-title": "J Med Chem"}, {"key": "ref471", "author": "Wainberg", "first-page": "673", "year": "2014", "article-title": "Safety and antitumor activity of the PARP inhibitor BMN in a phase trial recruiting metastatic small - cell lung cancer germline BRCA - mutation carrier cancer patients ASCO Annual Meeting Proceedings"}, {"key": "ref11", "author": "Piskunova", "first-page": "1", "year": "2008", "article-title": "Deficiency in poly ribose polymerase accelerates and spontaneous carcinogenesis in mice", "journal-title": "AI aging Curr Res"}, {"key": "ref121", "first-page": "362", "article-title": "Instability and decay of the primary structure of DNA", "volume": "13", "author": "Lindahl", "year": "1993", "journal-title": "Nature"}, {"key": "ref211", "first-page": "1", "article-title": "of does not interfere with the repair of DNA double - strand breaks but compromises the reactivation of stalled replication forks", "volume": "22", "author": "Yang", "year": "2004", "journal-title": "Oncogene"}, {"key": "ref401", "author": "Fong", "first-page": "361", "year": "2009", "article-title": "PC Inhibition of poly ribose polymerase in tumors from BRCA mutation carriers", "journal-title": "Engl J Med"}, {"key": "ref451", "author": "Puhalla", "first-page": "1", "year": "2014", "article-title": "Final results of a phase study of single - agent veliparib in patients pts with either BRCA - mutated cancer platinum - refractory ovarian or basal - like breast cancer wt Annual Meeting Proceedings"}, {"key": "ref271", "first-page": "26", "article-title": "Resistance - modifying agents Synthesis and biological properties of quinazolinone inhibitors of the DNA repair enzyme poly ribose polymerase", "volume": "28", "author": "Griffin", "year": "1998", "journal-title": "J Med Chem"}, {"key": "ref461", "author": "De Bono", "first-page": "673", "year": "2013", "article-title": "First - inhuman trial of novel oral PARP inhibitor in patients with solid tumors Annual Meeting Proceedings"}, {"key": "ref131", "doi-asserted-by": "crossref", "first-page": "39", "DOI": "10.1016/0006-291X(63)90024-X", "article-title": "Nicotinamide mono - nucleotide activation of a new DNA - dependent polyadenylic acid synthesizing nuclear enzyme", "volume": "14", "author": "Chambon", "year": "1963", "journal-title": "Biochem Biophys Res Commun"}, {"key": "ref151", "first-page": "342", "article-title": "ribosyl ation reactions in the regulation of nuclear functions", "volume": "16", "author": "Amours", "year": "1999", "journal-title": "Poly Biochem J"}, {"key": "ref221", "first-page": "1", "article-title": "ribose polymerase has a controlling role in homologous recombination", "volume": "23", "author": "Schultz", "year": "2003", "journal-title": "Poly Nucleic Acids Res"}, {"key": "ref01", "author": "Martin", "first-page": "1", "year": "2001", "article-title": "NM inhibition cancer therapy", "journal-title": "DNA repair J Photochem Photobiol"}, {"key": "ref311", "first-page": "1", "article-title": "synthesis and biological evaluation of novel imidazo pyri - dinecarboxamide derivatives as inhibitors", "volume": "4", "author": "Zhu", "year": "2013", "journal-title": "Design Bioorg Med Chem Lett"}, {"key": "ref101", "author": "Isabelle", "volume": "11", "year": "2010", "article-title": "Investigation of interactomes by affinity - purification mass spectrometry", "journal-title": "Proteome Sci"}, {"key": "ref361", "first-page": "37", "article-title": "molecule PARP modulators - current status and future therapeutic potential", "volume": "13", "author": "Penning", "year": "2010", "journal-title": "Small Curr Drug"}], "container-title": ["Folia Medica"], "link": [{"URL": "http://content.sciendo.com/view/journals/folmed/60/1/article-p39.xml", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.degruyter.com/view/j/folmed.2017.60.issue-1/folmed-2017-0067/folmed-2017-0067.pdf", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 10, 16]], "date-time": "2019-10-16T04:54:01Z", "timestamp": 1571201641000}, "score": 28.856638, "issued": {"date-parts": [[2018, 3, 1]]}, "references-count": 44, "journal-issue": {"issue": "1"}, "URL": "http://dx.doi.org/10.1515/folmed-2017-0067", "relation": {"cites": []}, "ISSN": ["1314-2143"], "issn-type": [{"value": "1314-2143", "type": "electronic"}], "subject": ["General Medicine"]}, {"indexed": {"date-parts": [[2019, 11, 26]], "date-time": "2019-11-26T11:19:39Z", "timestamp": 1574767179303}, "reference-count": 0, "publisher": "American Association for Cancer Research", "content-domain": {"domain": ["aacrjournals.org"], "crossmark-restriction": true}, "published-print": {"date-parts": [[2017, 4]]}, "DOI": "10.1158/1557-3125.dnarepair16-ia23", "type": "proceedings-article", "created": {"date-parts": [[2017, 4, 3]], "date-time": "2017-04-03T20:14:51Z", "timestamp": 1491250491000}, "update-policy": "http://dx.doi.org/10.1158/aacr-crossmark-policy", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Abstract IA23: Using PARP inhibitors to target ATM-deficient cancers"], "prefix": "10.1158", "author": [{"given": "Susan P.", "family": "Lees-Miller", "sequence": "first", "affiliation": []}], "member": "1086", "published-online": {"date-parts": [[2017, 4, 2]]}, "event": {"name": "Abstracts: AACR Special Conference on DNA Repair: Tumor Development and Therapeutic Response; November 2-5, 2016; Montreal, QC, Canada"}, "container-title": ["Therapies Targeting Checkpoints and Mismatch Repair"], "link": [{"URL": "https://syndication.highwire.org/content/doi/10.1158/1557-3125.DNAREPAIR16-IA23", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 5, 9]], "date-time": "2019-05-09T17:49:11Z", "timestamp": 1557424151000}, "score": 27.914206, "issued": {"date-parts": [[2017, 4]]}, "references-count": 0, "alternative-id": ["10.1158/1557-3125.DNAREPAIR16-IA23"], "URL": "http://dx.doi.org/10.1158/1557-3125.dnarepair16-ia23"}, {"indexed": {"date-parts": [[2019, 11, 26]], "date-time": "2019-11-26T00:40:19Z", "timestamp": 1574728819361}, "reference-count": 0, "publisher": "American Association for Cancer Research (AACR)", "issue": "1", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Cancer Discov"], "published-print": {"date-parts": [[2017, 1]]}, "DOI": "10.1158/2159-8290.cd-16-0860", "type": "journal-article", "created": {"date-parts": [[2016, 12, 22]], "date-time": "2016-12-22T01:36:53Z", "timestamp": 1482370613000}, "page": "20-37", "source": "Crossref", "is-referenced-by-count": 108, "title": ["Targeting DNA Repair in Cancer: Beyond PARP Inhibitors"], "prefix": "10.1158", "volume": "7", "author": [{"given": "Jessica S.", "family": "Brown", "sequence": "first", "affiliation": []}, {"given": "Brent", "family": "O'Carrigan", "sequence": "additional", "affiliation": []}, {"given": "Stephen P.", "family": "Jackson", "sequence": "additional", "affiliation": []}, {"given": "Timothy A.", "family": "Yap", "sequence": "additional", "affiliation": []}], "member": "1086", "published-online": {"date-parts": [[2016, 12, 21]]}, "container-title": ["Cancer Discovery"], "language": "en", "link": [{"URL": "https://syndication.highwire.org/content/doi/10.1158/2159-8290.CD-16-0860", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2018, 10, 23]], "date-time": "2018-10-23T18:10:59Z", "timestamp": 1540318259000}, "score": 27.815954, "issued": {"date-parts": [[2016, 12, 21]]}, "references-count": 0, "journal-issue": {"published-online": {"date-parts": [[2017, 1, 5]]}, "published-print": {"date-parts": [[2017, 1]]}, "issue": "1"}, "alternative-id": ["10.1158/2159-8290.CD-16-0860"], "URL": "http://dx.doi.org/10.1158/2159-8290.cd-16-0860", "ISSN": ["2159-8274", "2159-8290"], "issn-type": [{"value": "2159-8274", "type": "print"}, {"value": "2159-8290", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 24]], "date-time": "2019-11-24T04:56:43Z", "timestamp": 1574571403165}, "reference-count": 66, "publisher": "Elsevier BV", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2015, 2, 1]], "date-time": "2015-02-01T00:00:00Z", "timestamp": 1422748800000}, "delay-in-days": 0, "content-version": "tdm"}], "funder": [{"DOI": "10.13039/100002086", "name": "Cancer Center Amsterdam (CCA) and Fanconi Anemia Research Fund", "doi-asserted-by": "publisher", "award": []}], "content-domain": {"domain": ["elsevier.com", "sciencedirect.com"], "crossmark-restriction": true}, "short-container-title": ["DNA Repair"], "published-print": {"date-parts": [[2015, 2]]}, "DOI": "10.1016/j.dnarep.2014.12.003", "type": "journal-article", "created": {"date-parts": [[2014, 12, 24]], "date-time": "2014-12-24T05:30:29Z", "timestamp": 1419399029000}, "page": "54-64", "update-policy": "http://dx.doi.org/10.1016/elsevier_cm_policy", "source": "Crossref", "is-referenced-by-count": 12, "title": ["DNA helicases FANCM and DDX11 are determinants of PARP inhibitor sensitivity"], "prefix": "10.1016", "volume": "26", "author": [{"given": "Chantal", "family": "Stoepker", "sequence": "first", "affiliation": []}, {"given": "Atiq", "family": "Faramarz", "sequence": "additional", "affiliation": []}, {"given": "Martin A.", "family": "Rooimans", "sequence": "additional", "affiliation": []}, {"given": "Saskia E.", "family": "van Mil", "sequence": "additional", "affiliation": []}, {"given": "Jesper A.", "family": "Balk", "sequence": "additional", "affiliation": []}, {"given": "Eunike", "family": "Velleuer", "sequence": "additional", "affiliation": []}, {"given": "Najim", "family": "Ameziane", "sequence": "additional", "affiliation": []}, {"given": "Hein", "family": "te Riele", "sequence": "additional", "affiliation": []}, {"given": "Johan P.", "family": "de Winter", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["DNA Repair"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S1568786414002948?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S1568786414002948?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2018, 9, 26]], "date-time": "2018-09-26T18:59:37Z", "timestamp": 1537988377000}, "score": 27.29852, "issued": {"date-parts": [[2015, 2]]}, "references-count": 66, "alternative-id": ["S1568786414002948"], "URL": "http://dx.doi.org/10.1016/j.dnarep.2014.12.003", "ISSN": ["1568-7864"], "issn-type": [{"value": "1568-7864", "type": "print"}], "assertion": [{"value": "Elsevier", "name": "publisher", "label": "This article is maintained by"}, {"value": "DNA helicases FANCM and DDX11 are determinants of PARP inhibitor sensitivity", "name": "articletitle", "label": "Article Title"}, {"value": "DNA Repair", "name": "journaltitle", "label": "Journal Title"}, {"value": "https://doi.org/10.1016/j.dnarep.2014.12.003", "name": "articlelink", "label": "CrossRef DOI link to publisher maintained version"}, {"value": "article", "name": "content_type", "label": "Content Type"}, {"value": "Copyright \u00a9 2014 Elsevier B.V. All rights reserved.", "name": "copyright", "label": "Copyright"}]}, {"indexed": {"date-parts": [[2019, 12, 2]], "date-time": "2019-12-02T17:33:13Z", "timestamp": 1575307993474}, "publisher-location": "Totowa, NJ", "reference-count": 0, "publisher": "Humana Press", "isbn-type": [{"value": "9781588295132", "type": "print"}, {"value": "9781592599738", "type": "electronic"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "DOI": "10.1385/1-59259-973-7:201", "type": "book-chapter", "created": {"date-parts": [[2008, 9, 19]], "date-time": "2008-09-19T16:53:03Z", "timestamp": 1221843183000}, "page": "201-214", "source": "Crossref", "is-referenced-by-count": 5, "title": ["Measuring the Formation and Repair of DNA Damage by Ligation-Mediated PCR"], "prefix": "10.1007", "author": [{"given": "Gerd P.", "family": "Pfeifer", "sequence": "first", "affiliation": []}], "member": "297", "container-title": ["Methods in Molecular Biology", "DNA Repair Protocols"], "deposited": {"date-parts": [[2013, 1, 3]], "date-time": "2013-01-03T14:20:06Z", "timestamp": 1357222806000}, "score": 26.907333, "issued": {"date-parts": [[null]]}, "ISBN": ["9781588295132", "9781592599738"], "references-count": 0, "URL": "http://dx.doi.org/10.1385/1-59259-973-7:201", "ISSN": ["1064-3745"], "issn-type": [{"value": "1064-3745", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 26]], "date-time": "2019-11-26T17:28:41Z", "timestamp": 1574789321014}, "reference-count": 0, "publisher": "ECO-Vector LLC", "issue": "2", "license": [{"URL": "http://creativecommons.org/licenses/by-nc-sa/4.0", "start": {"date-parts": [[2016, 4, 15]], "date-time": "2016-04-15T00:00:00Z", "timestamp": 1460678400000}, "delay-in-days": 0, "content-version": "unspecified"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Kazan Med J"], "abstract": "<jats:p>Aim. To study the mechanisms of doxorubicin genotoxic effects in terms of poly-(ADP)-ribose-polymerase (PARP) and the ATM-kinase (Ataxia Telangiectasia Mutated) inhibition in cell lines with different p53 status.Methods. The study was conducted on BJ and BJp53DD human fibroblasts cell lines, cultured in DMEM medium supplemented with fetal bovine serum, L-glutamine and antibiotics. Inhibition of PARP and ATM-kinase activity was attained by adding synthetic inhibitors Nu1025 and Ku55933 respectively. Chemotherapy drug doxorubicin was used to induce deoxyribonucleic acid (DNA) damages. Cell viability analysis was performed using MTS-test. Repair system proteins and apoptotic markers expression was assessed by western blotting. Cells distribution by cell cycle phases was performed by flow cytometry.Results. Adding PARP and ATM-kinase inhibitors to the BJ p53DD cell line culture resulted in a significant reduction in the viable cells number amid DNA damage induction caused by doxorubicin. Cell death in these samples occurs according to the apoptosis mechanism, what was confirmed by the increase in hypodiploid cells number and increased expression of cleaved forms of PARP-1 and caspase-3. The above-described effects of the type II topoisomerase inhibitor doxorubicin were significantly higher in BJ fibroblasts line with non-functional p53 protein (p53DD) compared with conventional BJ human fibroblasts line.Conclusion. In the context of the failure of p53-dependent mechanisms of cell cycle regulation in BJ p53DD human fibroblasts, PARP and ATM-kinase activity inhibition leads to increased cell death by apoptosis mechanism induced by the doxorubicin action.</jats:p>", "DOI": "10.17750/kmj2016-245", "type": "journal-article", "created": {"date-parts": [[2016, 4, 25]], "date-time": "2016-04-25T14:49:05Z", "timestamp": 1461595745000}, "page": "245-249", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Role of P53 protein in activation of atm- and parp-mediated dna damage repair (DDR) pathways induced by topoisomerase type II inhibitors"], "prefix": "10.17816", "volume": "97", "author": [{"given": "B R", "family": "Ramazanov", "sequence": "first", "affiliation": []}, {"given": "R R", "family": "Khusnutdinov", "sequence": "additional", "affiliation": []}, {"given": "A R", "family": "Galembikova", "sequence": "additional", "affiliation": []}, {"given": "P D", "family": "Dunaev", "sequence": "additional", "affiliation": []}, {"given": "S V", "family": "Boichuk", "sequence": "additional", "affiliation": []}], "member": "7284", "published-online": {"date-parts": [[2016, 4, 15]]}, "container-title": ["Kazan medical journal"], "link": [{"URL": "https://journals.eco-vector.com/kazanmedj/article/viewFile/2910/2520", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://journals.eco-vector.com/kazanmedj/article/viewFile/2910/2520", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2018, 4, 27]], "date-time": "2018-04-27T19:03:05Z", "timestamp": 1524855785000}, "score": 26.62905, "issued": {"date-parts": [[2016, 4, 15]]}, "references-count": 0, "journal-issue": {"published-online": {"date-parts": [[2016, 4, 15]]}, "issue": "2"}, "URL": "http://dx.doi.org/10.17750/kmj2016-245", "ISSN": ["2587-9359", "0368-4814"], "issn-type": [{"value": "0368-4814", "type": "print"}, {"value": "2587-9359", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 25]], "date-time": "2019-11-25T22:33:51Z", "timestamp": 1574721231409}, "reference-count": 0, "publisher": "American Association for Cancer Research", "content-domain": {"domain": ["aacrjournals.org"], "crossmark-restriction": true}, "published-print": {"date-parts": [[2015, 8, 15]]}, "DOI": "10.1158/1557-3265.ovcasymp14-as23", "type": "proceedings-article", "created": {"date-parts": [[2015, 8, 19]], "date-time": "2015-08-19T00:09:45Z", "timestamp": 1439942985000}, "update-policy": "http://dx.doi.org/10.1158/aacr-crossmark-policy", "source": "Crossref", "is-referenced-by-count": 1, "title": ["Abstract AS23: Microenvironment mediated downregulation of miR-193b promotes ovarian cancer metastasis"], "prefix": "10.1158", "author": [{"given": "AK", "family": "Mitra", "sequence": "first", "affiliation": []}, {"given": "CY", "family": "Chiang", "sequence": "additional", "affiliation": []}, {"given": "P", "family": "Tiwari", "sequence": "additional", "affiliation": []}, {"given": "ME", "family": "Peter", "sequence": "additional", "affiliation": []}, {"given": "E", "family": "Lengyel", "sequence": "additional", "affiliation": []}], "member": "1086", "published-online": {"date-parts": [[2015, 8, 13]]}, "event": {"name": "Abstracts: 10th Biennial Ovarian Cancer Research Symposium; September 8-9, 2014; Seattle, WA"}, "container-title": ["Biology of Ovarian Cancer"], "link": [{"URL": "https://syndication.highwire.org/content/doi/10.1158/1557-3265.OVCASYMP14-AS23", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 5, 9]], "date-time": "2019-05-09T17:58:15Z", "timestamp": 1557424695000}, "score": 26.30885, "issued": {"date-parts": [[2015, 8, 13]]}, "references-count": 0, "alternative-id": ["10.1158/1557-3265.OVCASYMP14-AS23"], "URL": "http://dx.doi.org/10.1158/1557-3265.ovcasymp14-as23"}, {"indexed": {"date-parts": [[2019, 11, 23]], "date-time": "2019-11-23T20:08:28Z", "timestamp": 1574539708098}, "reference-count": 17, "publisher": "Elsevier", "isbn-type": [{"value": "9780123226501", "type": "print"}], "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[1978, 1, 1]], "date-time": "1978-01-01T00:00:00Z", "timestamp": 252460800000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[1978]]}, "DOI": "10.1016/b978-0-12-322650-1.50033-3", "type": "book-chapter", "created": {"date-parts": [[2014, 8, 15]], "date-time": "2014-08-15T22:11:05Z", "timestamp": 1408140665000}, "page": "179-182", "source": "Crossref", "is-referenced-by-count": 2, "title": ["DNA GLYCOSYLASES OF ESCHERICHIA COLI"], "prefix": "10.1016", "author": [{"given": "T.", "family": "Lindahl", "sequence": "first", "affiliation": []}, {"given": "P.", "family": "Karran", "sequence": "additional", "affiliation": []}, {"given": "S.", "family": "Riazuddin", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["DNA Repair Mechanisms"], "link": [{"URL": "https://api.elsevier.com/content/article/PII:B9780123226501500333?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:B9780123226501500333?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2018, 10, 10]], "date-time": "2018-10-10T17:21:42Z", "timestamp": 1539192102000}, "score": 26.126074, "issued": {"date-parts": [[1978]]}, "ISBN": ["9780123226501"], "references-count": 17, "URL": "http://dx.doi.org/10.1016/b978-0-12-322650-1.50033-3"}, {"indexed": {"date-parts": [[2019, 11, 26]], "date-time": "2019-11-26T20:11:48Z", "timestamp": 1574799108827}, "reference-count": 0, "publisher": "American Association for Cancer Research", "content-domain": {"domain": ["aacrjournals.org"], "crossmark-restriction": true}, "published-print": {"date-parts": [[2015, 12]]}, "DOI": "10.1158/1535-7163.targ-15-c15", "type": "proceedings-article", "created": {"date-parts": [[2016, 5, 20]], "date-time": "2016-05-20T08:59:19Z", "timestamp": 1463734759000}, "update-policy": "http://dx.doi.org/10.1158/aacr-crossmark-policy", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Abstract C15: Predicting response to PARP inhibitors through quantitative measurements of PARP activity in live BRCA1 mutated cells with a radio-iodinated PARP inhibitor"], "prefix": "10.1158", "author": [{"given": "Mehran", "family": "Makvandi", "sequence": "first", "affiliation": []}, {"given": "Brian P.", "family": "Lieberman", "sequence": "additional", "affiliation": []}, {"given": "Kuiying", "family": "Xu", "sequence": "additional", "affiliation": []}, {"given": "Redmond-Craig", "family": "Anderson", "sequence": "additional", "affiliation": []}, {"given": "Chenbo", "family": "Zeng", "sequence": "additional", "affiliation": []}, {"given": "David A.", "family": "Mankoff", "sequence": "additional", "affiliation": []}, {"given": "Daniel A.", "family": "Pryma", "sequence": "additional", "affiliation": []}, {"given": "Roger A.", "family": "Greenberg", "sequence": "additional", "affiliation": []}, {"given": "Robert H.", "family": "Mach", "sequence": "additional", "affiliation": []}], "member": "1086", "published-online": {"date-parts": [[2016, 1, 7]]}, "event": {"name": "Abstracts: AACR-NCI-EORTC International Conference: Molecular Targets and Cancer Therapeutics; November 5-9, 2015; Boston, MA"}, "container-title": ["Biomarkers"], "link": [{"URL": "https://syndication.highwire.org/content/doi/10.1158/1535-7163.TARG-15-C15", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 5, 9]], "date-time": "2019-05-09T19:40:57Z", "timestamp": 1557430857000}, "score": 25.890484, "issued": {"date-parts": [[2015, 12]]}, "references-count": 0, "alternative-id": ["10.1158/1535-7163.TARG-15-C15"], "URL": "http://dx.doi.org/10.1158/1535-7163.targ-15-c15"}, {"indexed": {"date-parts": [[2019, 12, 19]], "date-time": "2019-12-19T23:14:41Z", "timestamp": 1576797281022}, "reference-count": 0, "publisher": "American Society of Clinical Oncology (ASCO)", "issue": "15_suppl", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["JCO"], "published-print": {"date-parts": [[2019, 5, 20]]}, "DOI": "10.1200/jco.2019.37.15_suppl.2047", "type": "journal-article", "created": {"date-parts": [[2019, 5, 27]], "date-time": "2019-05-27T15:57:46Z", "timestamp": 1558972666000}, "page": "2047-2047", "source": "Crossref", "is-referenced-by-count": 0, "title": ["EGFR amplification predicted selective sensitivity to PARP inhibitors with high PARP-DNA trapping potential in human GBM."], "prefix": "10.1200", "volume": "37", "author": [{"given": "W. K. Alfred", "family": "Yung", "sequence": "first", "affiliation": [{"name": "The University of Texas MD Anderson Cancer Center, Department of Neuro-Oncology, Houston, TX;"}]}, {"given": "Shaofang", "family": "Wu", "sequence": "additional", "affiliation": [{"name": "MD Anderson Cancer Center, Houston, TX;"}]}, {"given": "Feng", "family": "Gao", "sequence": "additional", "affiliation": [{"name": "MD Anderson Cancer Center, Houston, TX;"}]}, {"given": "Siyuan", "family": "Zheng", "sequence": "additional", "affiliation": [{"name": "University of Texas at San Antonio, San Antonio, TX;"}]}, {"given": "Jie", "family": "Ding", "sequence": "additional", "affiliation": [{"name": "MD Anderson Cancer Center, Houston, TX;"}]}, {"given": "Chen", "family": "Zhang", "sequence": "additional", "affiliation": [{"name": "MD Anderson Cancer Center, Houston, TX;"}]}, {"given": "Xialong", "family": "Li", "sequence": "additional", "affiliation": [{"name": "MD Anderson Cancer Center, Houston, TX;"}]}, {"given": "Ravesanker", "family": "Ezhilarasan", "sequence": "additional", "affiliation": [{"name": "The University of Texas MD Anderson Cancer Center, Houston, TX;"}]}, {"given": "Ningping", "family": "Feng", "sequence": "additional", "affiliation": [{"name": "MD Anderson Cancer Center, Houston, TX;"}]}, {"given": "John Frederick", "family": "De Groot", "sequence": "additional", "affiliation": [{"name": "The University of Texas MD Anderson Cancer Center, Houston, TX;"}]}, {"given": "Erik P.", "family": "Sulman", "sequence": "additional", "affiliation": [{"name": "The University of Texas MD Anderson Cancer Center, Houston, TX;"}]}, {"given": "Timothy", "family": "Heffernan", "sequence": "additional", "affiliation": [{"name": "UT MD Anderson Cancer Center, Houston, TX;"}]}, {"given": "Dimpy", "family": "Koul", "sequence": "additional", "affiliation": [{"name": "University of Texas MD Anderson Cancer Center, Houston, TX;"}]}], "member": "233", "container-title": ["Journal of Clinical Oncology"], "language": "en", "link": [{"URL": "http://ascopubs.org/doi/pdfdirect/10.1200/JCO.2019.37.15_suppl.2047", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 11, 27]], "date-time": "2019-11-27T20:54:55Z", "timestamp": 1574888095000}, "score": 25.05611, "issued": {"date-parts": [[2019, 5, 20]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2019, 5, 20]]}, "issue": "15_suppl"}, "alternative-id": ["10.1200/JCO.2019.37.15_suppl.2047"], "URL": "http://dx.doi.org/10.1200/jco.2019.37.15_suppl.2047", "ISSN": ["0732-183X", "1527-7755"], "issn-type": [{"value": "0732-183X", "type": "print"}, {"value": "1527-7755", "type": "electronic"}], "subject": ["Cancer Research", "Oncology"]}, {"indexed": {"date-parts": [[2019, 11, 22]], "date-time": "2019-11-22T05:11:19Z", "timestamp": 1574399479279}, "publisher-location": "Totowa, NJ", "reference-count": 32, "publisher": "Humana Press", "isbn-type": [{"value": "9781468471441", "type": "print"}, {"value": "9781461216087", "type": "electronic"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[1999]]}, "DOI": "10.1007/978-1-4612-1608-7_18", "type": "book-chapter", "created": {"date-parts": [[2011, 9, 16]], "date-time": "2011-09-16T22:24:40Z", "timestamp": 1316211880000}, "page": "213-226", "source": "Crossref", "is-referenced-by-count": 1, "title": ["Measuring the Formation and Repair of UV Photoproducts by Ligation-Mediated PCR"], "prefix": "10.1007", "author": [{"given": "Gerd P.", "family": "Pfeifer", "sequence": "first", "affiliation": []}, {"given": "Reinhard", "family": "Dammann", "sequence": "additional", "affiliation": []}], "member": "297", "reference": [{"key": "18_CR1", "doi-asserted-by": "publisher", "first-page": "221", "DOI": "10.1002/bies.950180309", "volume": "18", "author": "S Tomaletti", "year": "1996", "unstructured": "Tomaletti, S. and Pfeifer, G. P. (1996) UV damage and repair mechanisms in mammalian cells. BioEssays\n                  18, 221\u2013228.", "journal-title": "BioEssays"}, {"key": "18_CR2", "doi-asserted-by": "publisher", "first-page": "270", "DOI": "10.1111/j.1751-1097.1997.tb08560.x", "volume": "65", "author": "GP Pfeifer", "year": "1997", "unstructured": "Pfeifer, G. P. (1997) Formation and processing of UV photoproducts: effects of DNA sequence and chromatin environment. Photochem. Photobiol.\n                  65, 270\u2013283.", "journal-title": "Photochem. Photobiol."}, {"key": "18_CR3", "doi-asserted-by": "publisher", "first-page": "163", "DOI": "10.1111/j.1751-1097.1993.tb02273.x", "volume": "57", "author": "E Sage", "year": "1993", "unstructured": "Sage, E. (1993) Distribution and repair of photolesions in DNA: genetic consequences and the role of sequence context. Photochem. Photobiol.\n                  57, 163\u2013174.", "journal-title": "Photochem. Photobiol."}, {"key": "18_CR4", "doi-asserted-by": "publisher", "first-page": "963", "DOI": "10.1093/nar/18.4.963", "volume": "18", "author": "DL Mitchell", "year": "1990", "unstructured": "Mitchell, D. L., Brash, D. E., and Nairn, R. S. (1990) Rapid repair kinetics of pyrimidine (6-4) pyrimidone photoproducts in human cells are due to excision repair rather than conformational change. Nucleic Acids Res.\n                  18, 963\u2013971.", "journal-title": "Nucleic Acids Res."}, {"key": "18_CR5", "doi-asserted-by": "publisher", "first-page": "59", "DOI": "10.1111/j.1751-1097.1988.tb02786.x", "volume": "48", "author": "DE Brash", "year": "1988", "unstructured": "Brash, D. E. (1988) UV mutagenic photoproducts in Escherichia coli and human cells: A molecular genetics perspective on human skin cancer. Photochem. Photobiol.\n                  48, 59\u201366.", "journal-title": "Photochem. Photobiol."}, {"key": "18_CR6", "doi-asserted-by": "publisher", "first-page": "805", "DOI": "10.1111/j.1751-1097.1989.tb05578.x", "volume": "49", "author": "DL Mitchell", "year": "1989", "unstructured": "Mitchell, D. L. and Nairn R. S. (1989) The biology of the (6-4) photoproduct. Photochem. Photobiol.\n                  49, 805\u2013819.", "journal-title": "Photochem. Photobiol."}, {"key": "18_CR7", "doi-asserted-by": "publisher", "first-page": "359", "DOI": "10.1016/0092-8674(85)90150-3", "volume": "40", "author": "VA Bohr", "year": "1985", "unstructured": "Bohr, V. A., Smith, C. A., Okumoto, D. S., and Hanawalt, P. C. (1985) DNA repair in an active gene: removal of pyrimidine dimers from the DHFR gene of CHO cells is much more efficient than in the genome overall. Cell\n                  40, 359\u2013369.", "journal-title": "Cell"}, {"key": "18_CR8", "doi-asserted-by": "publisher", "first-page": "241", "DOI": "10.1016/0092-8674(87)90151-6", "volume": "51", "author": "I Mellon", "year": "1987", "unstructured": "Mellon, I., Spivak, G., and Hanawalt, P. C. (1987) Selective removal of transcription blocking DNA damage from the transcribed strand of the mammalian DHFR gene. Cell\n                  51, 241\u2013249.", "journal-title": "Cell"}, {"key": "18_CR9", "doi-asserted-by": "crossref", "first-page": "2245", "DOI": "10.1128/MCB.11.4.2245", "volume": "11", "author": "J-M Vos", "year": "1991", "unstructured": "Vos, J.-M. and Wauthier, E. L. (1991) Differential introduction of DNA damage and repair in mammalian genes transcribed by RNA polymerase I and II. Mol. Cell. Biol.\n                  11, 2245\u20132252.", "journal-title": "Mol. Cell. Biol."}, {"key": "18_CR10", "doi-asserted-by": "publisher", "first-page": "10512", "DOI": "10.1021/bi00090a030", "volume": "32", "author": "FC Christians", "year": "1993", "unstructured": "Christians, F. C. and Hanawalt, P. C. (1993) Lack of transcription-coupled repair in mammalian ribosomal RNA genes. Biochemistry\n                  32, 10512\u201310518.", "journal-title": "Biochemistry"}, {"key": "18_CR11", "first-page": "1519", "volume": "14", "author": "T Stevnsner", "year": "1993", "unstructured": "Stevnsner, T., May, A., Petersen, L. N., Larminat, F., Pirsel, M., and Bohr, V. A. (1993) Repair of ribosomal RNA genes in hamster cells after UV irradiation, or treatment with cisplatin or alkylating agents. Carcinogenesis\n                  14, 1519\u20131596.", "journal-title": "Carcinogenesis"}, {"key": "18_CR12", "doi-asserted-by": "publisher", "first-page": "13117", "DOI": "10.1021/bi00040a024", "volume": "34", "author": "LK Fritz", "year": "1995", "unstructured": "Fritz, L. K. and Smerdon, M. J. (1995) Repair of UV damage in actively transcribed ribosomal genes. Biochemistry\n                  34, 13117\u201313124.", "journal-title": "Biochemistry"}, {"key": "18_CR13", "doi-asserted-by": "crossref", "first-page": "219", "DOI": "10.1128/MCB.17.1.219", "volume": "17", "author": "R Dammann", "year": "1997", "unstructured": "Dammann, R. and Pfeifer, G. P. (1997) Lack of gene-and strand-specific DNA repair in RNA polymerase III transcribed human tRNA genes. Mol. Cell. Biol.\n                  17, 219\u2013229.", "journal-title": "Mol. Cell. Biol."}, {"key": "18_CR14", "doi-asserted-by": "publisher", "first-page": "652", "DOI": "10.1038/218652a0", "volume": "218", "author": "JE Cleaver", "year": "1968", "unstructured": "Cleaver, J. E. (1968) Defective repair replication of DNA in xeroderma pigmentosum. Nature\n                  218, 652\u2013656.", "journal-title": "Nature"}, {"key": "18_CR15", "doi-asserted-by": "publisher", "first-page": "83", "DOI": "10.1016/0968-0004(94)90040-X", "volume": "19", "author": "K Tanaka", "year": "1994", "unstructured": "Tanaka, K. and Wood, R. D. (1994) Xeroderma pigmentosum and nucleotide excision repair of DNA. Trends Biochem. Sci.\n                  19, 83\u201386.", "journal-title": "Trends Biochem. Sci."}, {"key": "18_CR16", "doi-asserted-by": "publisher", "first-page": "731", "DOI": "10.1002/bies.950180908", "volume": "18", "author": "EC Friedberg", "year": "1996", "unstructured": "Friedberg, E. C. (1996) Cockayne syndrome\u2014a primary defect in DNA repair, transcription, both or neither? BioEssays\n                  18, 731\u2013738.", "journal-title": "BioEssays"}, {"key": "18_CR17", "doi-asserted-by": "publisher", "first-page": "124", "DOI": "10.1016/0168-9525(86)90201-5", "volume": "2", "author": "PC Hanawalt", "year": "1986", "unstructured": "Hanawalt, P. C. and Sarasin, A. (1986) Cancer-prone hereditary diseases with DNA processing abnormalities. Trends Genet.\n                  2, 124\u2013129.", "journal-title": "Trends Genet."}, {"key": "18_CR18", "doi-asserted-by": "publisher", "first-page": "1374", "DOI": "10.1073/pnas.88.4.1374", "volume": "88", "author": "GP Pfeifer", "year": "1991", "unstructured": "Pfeifer, G. P., Drouin, R., Riggs, A. D., and Holmquist, G. P. (1991) In vivo mapping of a DNA adduct at nucleotide resolution: detection of pyrimidine (6-4) pyrimidone photoproducts by ligation-mediated polymerase chain reaction. Proc. Natl. Acad. Sci. U. S. A.\n                  88, 1374\u20131378.", "journal-title": "Proc. Natl. Acad. Sci. U. S. A."}, {"key": "18_CR19", "doi-asserted-by": "crossref", "first-page": "1798", "DOI": "10.1128/MCB.12.4.1798", "volume": "12", "author": "GP Pfeifer", "year": "1992", "unstructured": "Pfeifer, G. P., Drouin, R., Riggs, A. D., and Holmquist, G. P. (1992) Binding of transcription factors creates hot spots for UV photoproducts in vivo. Mol. Cell. Biol.\n                  12, 1798\u20131804.", "journal-title": "Mol. Cell. Biol."}, {"key": "18_CR20", "first-page": "1729", "volume": "7", "author": "VT T\u00f6rm\u00e4nen", "year": "1992", "unstructured": "T\u00f6rm\u00e4nen, V. T. and Pfeifer, G. P. (1992) Mapping of UV photoproducts within ras protooncogenes in UV-irradiated cells: correlation with mutations in human skin cancer. Oncogene\n                  7, 1729\u20131736.", "journal-title": "Oncogene"}, {"key": "18_CR21", "first-page": "2051", "volume": "8", "author": "S T\u00f6rn\u00e4letti", "year": "1993", "unstructured": "T\u00f6rn\u00e4letti, S., Rozek, D., and Pfeifer G. P. (1993) The distribution of UV photoproducts along the human p53 gene and its relation to mutations in skin cancer. Oncogene\n                  8, 2051\u20132057.", "journal-title": "Oncogene"}, {"key": "18_CR22", "doi-asserted-by": "publisher", "first-page": "1436", "DOI": "10.1126/science.8128225", "volume": "263", "author": "S Tornaletti", "year": "1994", "unstructured": "Tornaletti, S. and Pfeifer G. P. (1994) Slow repair of pyrimidine dimers at p53 mutation hotspots in skin cancer. Science\n                  263, 1436\u20131438.", "journal-title": "Science"}, {"key": "18_CR23", "doi-asserted-by": "crossref", "first-page": "675", "DOI": "10.1002/j.1460-2075.1996.tb00400.x", "volume": "15", "author": "Y Tu", "year": "1996", "unstructured": "Tu, Y., Tomaletti, S., and Pfeifer, G. P. (1996) DNA repair domains within a human gene: selective repair of sequences near the transcription initiation site. EMBO J.\n                  15, 675\u2013683.", "journal-title": "EMBO J."}, {"key": "18_CR24", "doi-asserted-by": "publisher", "first-page": "20", "DOI": "10.1074/jbc.272.1.20", "volume": "272", "author": "Y Tu", "year": "1997", "unstructured": "Tu, Y., Bates, S., and Pfeifer, G. P. (1997) Sequence-specific and domain-specific DNA repair in xeroderma pigmentosum and Cockayne syndrome cells. J. Biol. Chem.\n                  272, 20, 747-20, 755.", "journal-title": "J. Biol. Chem."}, {"key": "18_CR25", "doi-asserted-by": "publisher", "first-page": "1438", "DOI": "10.1126/science.8128226", "volume": "263", "author": "S Gao", "year": "1994", "unstructured": "Gao, S., Drouin, R., and Holmquist, G. P. (1994) DNA repair rates mapped along the human PGK-1 gene at nucleotide resolution. Science\n                  263, 1438\u20131440.", "journal-title": "Science"}, {"key": "18_CR26", "doi-asserted-by": "publisher", "first-page": "3388", "DOI": "10.1073/pnas.78.6.3388", "volume": "78", "author": "JA Lippke", "year": "1981", "unstructured": "Lippke, J. A., Gordon, L. K., Brash, D. E., and Haseltine, W. A. (1981) Distribution of UV light-induced damage in a defined sequence of human DNA: detection of alkaline-sensitive lesions at pyrimidine nucleoside-cytidine sequences. Proc. Natl. Acad. Sci. USA\n                  78, 3388\u20133392.", "journal-title": "Proc. Natl. Acad. Sci. USA"}, {"key": "18_CR27", "first-page": "12", "volume": "255", "author": "LK Gordon", "year": "1980", "unstructured": "Gordon, L. K. and Haseltine W. A. (1980) Comparison of the cleavage of pyrimidine dimers by the bacteriophage T4 and Micrococcus luteus UV-specific endonucleases. J. Biol. Chem.\n                  255, 12, 047-12, 050.", "journal-title": "J. Biol. Chem."}, {"key": "18_CR28", "author": "GP Pfeifer", "first-page": "169", "year": "1993", "unstructured": "Pfeifer, G. P. and Riggs, A. D. (1993) Genomic sequencing, in Methods in Molecular Biology, vol. 23, DNA Sequencing Protocols (Griffin, H. and Griffin, A., eds.), Humana, Totowa, NJ, pp. 169\u2013181.", "volume-title": "Methods in Molecular Biology"}, {"key": "18_CR29", "doi-asserted-by": "publisher", "first-page": "810", "DOI": "10.1126/science.2814502", "volume": "246", "author": "GP Pfeifer", "year": "1989", "unstructured": "Pfeifer, G. P., Steigerwald, S. D., Mueller, P. R., Wold, B., and Riggs, A. D. (1989) Genomic sequencing and methylation analysis by ligation mediated PCR. Science\n                  246, 810\u2013813.", "journal-title": "Science"}, {"key": "18_CR30", "doi-asserted-by": "publisher", "first-page": "8543", "DOI": "10.1093/nar/17.21.8543", "volume": "17", "author": "W Rychlik", "year": "1989", "unstructured": "Rychlik, W. and Rhoads, R. E. (1989) A computer program for choosing optimal oligonucleotides for filter hybridization, sequencing and in vitro amplification of DNA. Nucleic Acids Res.\n                  17, 8543\u20138551.", "journal-title": "Nucleic Acids Res."}, {"key": "18_CR31", "doi-asserted-by": "publisher", "first-page": "780", "DOI": "10.1126/science.2814500", "volume": "246", "author": "PR Mueller", "year": "1989", "unstructured": "Mueller, P. R. and Wold, B. (1989) In vivo footprinting of a muscle specific enhancer by ligation mediated PCR. Science\n                  246, 780\u2013786.", "journal-title": "Science"}, {"key": "18_CR32", "author": "S Tomaletti", "first-page": "199", "year": "1996", "unstructured": "Tomaletti, S. and Pfeifer, G. P. (1996) Ligation-mediated PCR for analysis of UV damage, in Technologies for Detection of DNA Damage and Mutations (Pfeifer, G. P., ed.), Plenum, New York, pp. 199\u2013209.", "volume-title": "Technologies for Detection of DNA Damage and Mutations", "DOI": "10.1007/978-1-4899-0301-3_15", "doi-asserted-by": "crossref"}], "container-title": ["DNA Repair Protocols"], "link": [{"URL": "http://link.springer.com/content/pdf/10.1007/978-1-4612-1608-7_18", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 4, 6]], "date-time": "2019-04-06T17:14:50Z", "timestamp": 1554570890000}, "score": 24.585121, "issued": {"date-parts": [[1999]]}, "ISBN": ["9781468471441", "9781461216087"], "references-count": 32, "URL": "http://dx.doi.org/10.1007/978-1-4612-1608-7_18", "relation": {"cites": []}}, {"indexed": {"date-parts": [[2019, 11, 30]], "date-time": "2019-11-30T09:21:02Z", "timestamp": 1575105662955}, "publisher-location": "New Jersey", "reference-count": 0, "publisher": "Humana Press", "isbn-type": [{"value": "1592596754", "type": "print"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "DOI": "10.1385/1-59259-675-4:213", "type": "book-chapter", "created": {"date-parts": [[2003, 11, 15]], "date-time": "2003-11-15T02:10:29Z", "timestamp": 1068862229000}, "page": "213-226", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Measuring the Formation and Repair of UV Photoproducts by Ligation-Mediated PCR"], "prefix": "10.1007", "author": [{"given": "Gerd P.", "family": "Pfeifer", "sequence": "first", "affiliation": []}, {"given": "Reinhard", "family": "Dammann", "sequence": "additional", "affiliation": []}], "member": "297", "container-title": ["DNA Repair Protocols"], "deposited": {"date-parts": [[2013, 1, 3]], "date-time": "2013-01-03T13:32:55Z", "timestamp": 1357219975000}, "score": 24.585121, "issued": {"date-parts": [[null]]}, "ISBN": ["1592596754"], "references-count": 0, "URL": "http://dx.doi.org/10.1385/1-59259-675-4:213"}, {"indexed": {"date-parts": [[2019, 11, 23]], "date-time": "2019-11-23T14:23:05Z", "timestamp": 1574518985941}, "publisher-location": "Totowa, NJ", "reference-count": 26, "publisher": "Humana Press", "isbn-type": [{"value": "9781617799976", "type": "print"}, {"value": "9781617799983", "type": "electronic"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[2012]]}, "DOI": "10.1007/978-1-61779-998-3_14", "type": "book-chapter", "created": {"date-parts": [[2012, 11, 30]], "date-time": "2012-11-30T19:48:25Z", "timestamp": 1354304905000}, "page": "189-202", "source": "Crossref", "is-referenced-by-count": 15, "title": ["Measuring the Formation and Repair of UV Damage at the DNA Sequence Level by Ligation-Mediated PCR"], "prefix": "10.1007", "author": [{"given": "Ahmad", "family": "Besaratinia", "sequence": "first", "affiliation": []}, {"given": "Gerd P.", "family": "Pfeifer", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2012, 7, 23]]}, "reference": [{"key": "14_CR1", "doi-asserted-by": "publisher", "first-page": "19", "DOI": "10.1016/j.mrfmmm.2004.06.057", "volume": "571", "author": "GP Pfeifer", "year": "2005", "unstructured": "Pfeifer GP, You YH, Besaratinia A (2005) Mutations induced by ultraviolet light. Mutat Res 571:19\u201331", "journal-title": "Mutat Res"}, {"key": "14_CR2", "doi-asserted-by": "publisher", "first-page": "681", "DOI": "10.1006/jmbi.2000.3771", "volume": "299", "author": "J-H Yoon", "year": "2000", "unstructured": "Yoon J-H, Lee C-S, O\u2019Connor T, Yasui A, Pfeifer GP (2000) The DNA damage spectrum produced by simulated sunlight. J Mol Biol 299:681\u2013693", "journal-title": "J Mol Biol"}, {"key": "14_CR3", "doi-asserted-by": "publisher", "first-page": "44688", "DOI": "10.1074/jbc.M107696200", "volume": "276", "author": "YH You", "year": "2001", "unstructured": "You YH, Lee DH, Yoon JH, Nakajima S, Yasui A, Pfeifer GP (2001) Cyclobutane pyrimidine dimers are responsible for the vast majority of mutations induced by UVB irradiation in mammalian cells. J Biol Chem 276:44688\u201344694", "journal-title": "J Biol Chem"}, {"key": "14_CR4", "doi-asserted-by": "publisher", "first-page": "805", "DOI": "10.1111/j.1751-1097.1989.tb05578.x", "volume": "49", "author": "DL Mitchell", "year": "1989", "unstructured": "Mitchell DL, Nairn RS (1989) The biology of the (6-4) photoproduct. Photochem Photobiol 49:805\u2013819", "journal-title": "Photochem Photobiol"}, {"key": "14_CR5", "doi-asserted-by": "publisher", "first-page": "119", "DOI": "10.1111/j.1755-148X.2010.00789.x", "volume": "24", "author": "DL Mitchell", "year": "2011", "unstructured": "Mitchell DL, Fernandez AA (2011) Different types of DNA damage play different roles in the etiology of sunlight-induced melanoma. Pigment Cell Melanoma Res 24:119\u2013124", "journal-title": "Pigment Cell Melanoma Res"}, {"key": "14_CR6", "doi-asserted-by": "publisher", "first-page": "241", "DOI": "10.1016/0092-8674(87)90151-6", "volume": "51", "author": "I Mellon", "year": "1987", "unstructured": "Mellon I, Spivak G, Hanawalt PC (1987) Selective removal of transcription blocking DNA damage from the transcribed strand of the mammalian DHFR gene. Cell 51:241\u2013249", "journal-title": "Cell"}, {"key": "14_CR7", "doi-asserted-by": "publisher", "first-page": "359", "DOI": "10.1016/0092-8674(85)90150-3", "volume": "40", "author": "VA Bohr", "year": "1985", "unstructured": "Bohr VA, Smith CA, Okumoto DS, Hanawalt PC (1985) DNA repair in an active gene: removal of pyrimidine dimers from the DHFR gene of CHO cells is much more efficient than in the genome overall. Cell 40:359\u2013369", "journal-title": "Cell"}, {"key": "14_CR8", "doi-asserted-by": "publisher", "first-page": "652", "DOI": "10.1038/218652a0", "volume": "218", "author": "JE Cleaver", "year": "1968", "unstructured": "Cleaver JE (1968) Defective repair replication of DNA in xeroderma pigmentosum. Nature 218:652\u2013656", "journal-title": "Nature"}, {"key": "14_CR9", "doi-asserted-by": "publisher", "first-page": "124", "DOI": "10.1016/0168-9525(86)90201-5", "volume": "2", "author": "PC Hanawalt", "year": "1986", "unstructured": "Hanawalt PC, Sarasin A (1986) Cancer-prone hereditary diseases with DNA processing abnormalities. Trends Genet 2:124\u2013129", "journal-title": "Trends Genet"}, {"key": "14_CR10", "doi-asserted-by": "crossref", "first-page": "219", "DOI": "10.1128/MCB.17.1.219", "volume": "17", "author": "R Dammann", "year": "1997", "unstructured": "Dammann R, Pfeifer GP (1997) Lack of gene- and strand-specific DNA repair in RNA polymerase III transcribed human tRNA genes. Mol Cell Biol 17:219\u2013229", "journal-title": "Mol Cell Biol"}, {"key": "14_CR11", "doi-asserted-by": "publisher", "first-page": "1438", "DOI": "10.1126/science.8128226", "volume": "263", "author": "S Gao", "year": "1994", "unstructured": "Gao S, Drouin R, Holmquist GP (1994) DNA repair rates mapped along the human PGK-1 gene at nucleotide resolution. Science 263:1438\u20131440", "journal-title": "Science"}, {"key": "14_CR12", "doi-asserted-by": "publisher", "first-page": "1374", "DOI": "10.1073/pnas.88.4.1374", "volume": "88", "author": "GP Pfeifer", "year": "1991", "unstructured": "Pfeifer GP, Drouin R, Riggs AD, Holmquist GP (1991) In vivo mapping of a DNA adduct at nucleotide resolution: detection of pyrimidine (6-4) pyrimidone photoproducts by ligation-mediated polymerase chain reaction. Proc Natl Acad Sci USA 88:1374\u20131378", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "14_CR13", "doi-asserted-by": "crossref", "first-page": "1798", "DOI": "10.1128/MCB.12.4.1798", "volume": "12", "author": "GP Pfeifer", "year": "1992", "unstructured": "Pfeifer GP, Drouin R, Riggs AD, Holmquist GP (1992) Binding of transcription factors creates hot spots for UV photoproducts in vivo. Mol Cell Biol 12:1798\u20131804", "journal-title": "Mol Cell Biol"}, {"key": "14_CR14", "doi-asserted-by": "publisher", "first-page": "1436", "DOI": "10.1126/science.8128225", "volume": "263", "author": "S Tornaletti", "year": "1994", "unstructured": "Tornaletti S, Pfeifer GP (1994) Slow repair of pyrimidine dimers at p53 mutation hotspots in skin cancer. Science 263:1436\u20131438", "journal-title": "Science"}, {"key": "14_CR15", "author": "S Tornaletti", "first-page": "199", "year": "1996", "unstructured": "Tornaletti S, Pfeifer GP (1996) Ligation-mediated PCR for analysis of UV damage. In: Pfeifer GP (ed) Technologies for detection of DNA damage and mutations. Plenum, New York, pp 199\u2013209", "volume-title": "Technologies for detection of DNA damage and mutations", "DOI": "10.1007/978-1-4899-0301-3_15", "doi-asserted-by": "crossref"}, {"key": "14_CR16", "first-page": "1729", "volume": "7", "author": "VT T\u00f6rm\u00e4nen", "year": "1992", "unstructured": "T\u00f6rm\u00e4nen VT, Pfeifer GP (1992) Mapping of UV photoproducts within ras protooncogenes in UV-irradiated cells: correlation with mutations in human skin cancer. Oncogene 7:1729\u20131736", "journal-title": "Oncogene"}, {"key": "14_CR17", "doi-asserted-by": "crossref", "first-page": "675", "DOI": "10.1002/j.1460-2075.1996.tb00400.x", "volume": "15", "author": "Y Tu", "year": "1996", "unstructured": "Tu Y, Tornaletti S, Pfeifer GP (1996) DNA repair domains within a human gene: selective repair of sequences near the transcription initiation site. EMBO J 15:675\u2013683", "journal-title": "EMBO J"}, {"key": "14_CR18", "doi-asserted-by": "publisher", "first-page": "3991", "DOI": "10.1093/nar/28.20.3991", "volume": "28", "author": "S Tommasi", "year": "2000", "unstructured": "Tommasi S, Oxyzoglou AB, Pfeifer GP (2000) Cell cycle-independent removal of UV-induced pyrimidine dimers from the promoter and the transcription initiation domain of the human CDC2 gene. Nucleic Acids Res 28:3991\u20133998", "journal-title": "Nucleic Acids Res"}, {"key": "14_CR19", "doi-asserted-by": "publisher", "first-page": "38305", "DOI": "10.1074/jbc.M206375200", "volume": "277", "author": "W Hu", "year": "2002", "unstructured": "Hu W, Feng Z, Chasin LA, Tang MS (2002) Transcription-coupled and transcription-independent repair of cyclobutane pyrimidine dimers in the dihydrofolate reductase gene. J Biol Chem 277:38305\u201338310", "journal-title": "J Biol Chem"}, {"key": "14_CR20", "doi-asserted-by": "publisher", "first-page": "11492", "DOI": "10.1074/jbc.275.15.11492", "volume": "275", "author": "Q Zhu", "year": "2000", "unstructured": "Zhu Q, Wani MA, El-Mahdy M, Wani AA (2000) Decreased DNA repair efficiency by loss or disruption of p53 function preferentially affects removal of cyclobutane pyrimidine dimers from non-transcribed strand and slow repair sites in transcribed strand. J Biol Chem 275:11492\u201311497", "journal-title": "J Biol Chem"}, {"key": "14_CR21", "doi-asserted-by": "publisher", "first-page": "20747", "DOI": "10.1074/jbc.272.33.20747", "volume": "272", "author": "Y Tu", "year": "1997", "unstructured": "Tu Y, Bates S, Pfeifer GP (1997) Sequence-specific and domain-specific DNA repair in xeroderma pigmentosum and Cockayne syndrome cells. J Biol Chem 272:20747\u201320755", "journal-title": "J Biol Chem"}, {"key": "14_CR22", "doi-asserted-by": "publisher", "first-page": "170", "DOI": "10.1016/j.cub.2009.11.061", "volume": "20", "author": "G Hendriks", "year": "2010", "unstructured": "Hendriks G, Calleja F, Besaratinia A, Vrieling H, Pfeifer GP, Mullenders LH, Jansen JG, de Wind N (2010) Transcription-dependent cytosine deamination is a novel mechanism in ultraviolet light-induced mutagenesis. Curr Biol 20:170\u2013175", "journal-title": "Curr Biol"}, {"key": "14_CR23", "doi-asserted-by": "publisher", "first-page": "2379", "DOI": "10.1096/fj.07-105437", "volume": "22", "author": "A Besaratinia", "year": "2008", "unstructured": "Besaratinia A, Kim SI, Pfeifer GP (2008) Rapid repair of UVA-induced oxidized purines and persistence of UVB-induced dipyrimidine lesions determine the mutagenicity of sunlight in mouse cells. FASEB J 22:2379\u20132392", "journal-title": "FASEB J"}, {"key": "14_CR24", "doi-asserted-by": "publisher", "first-page": "3388", "DOI": "10.1073/pnas.78.6.3388", "volume": "78", "author": "JA Lippke", "year": "1981", "unstructured": "Lippke JA, Gordon LK, Brash DE, Haseltine WA (1981) Distribution of UV light-induced damage in a defined sequence of human DNA: detection of alkaline-sensitive lesions at pyrimidine nucleoside-cytidine sequences. Proc Natl Acad Sci USA 78:3388\u20133392", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "14_CR25", "first-page": "12047", "volume": "255", "author": "LK Gordon", "year": "1980", "unstructured": "Gordon LK, Haseltine WA (1980) Comparison of the cleavage of pyrimidine dimers by the bacteriophage T4 and Micrococcus luteus UV-specific endonucleases. J Biol Chem 255:12047\u201312050", "journal-title": "J Biol Chem"}, {"key": "14_CR26", "doi-asserted-by": "publisher", "first-page": "182", "DOI": "10.1038/286182a0", "volume": "286", "author": "EH Radany", "year": "1980", "unstructured": "Radany EH, Friedberg EC (1980) A pyrimidine dimer-DNA glycosylase activity associated with the v gene product of bacterophage T4. Nature 286:182\u2013185", "journal-title": "Nature"}], "container-title": ["Methods in Molecular Biology", "DNA Repair Protocols"], "link": [{"URL": "http://www.springerlink.com/index/pdf/10.1007/978-1-61779-998-3_14", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 5, 7]], "date-time": "2019-05-07T07:21:17Z", "timestamp": 1557213677000}, "score": 24.007816, "issued": {"date-parts": [[2012]]}, "ISBN": ["9781617799976", "9781617799983"], "references-count": 26, "URL": "http://dx.doi.org/10.1007/978-1-61779-998-3_14", "relation": {"cites": []}, "ISSN": ["1064-3745", "1940-6029"], "issn-type": [{"value": "1064-3745", "type": "print"}, {"value": "1940-6029", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 12, 3]], "date-time": "2019-12-03T01:02:11Z", "timestamp": 1575334931860}, "reference-count": 0, "publisher": "Walter de Gruyter GmbH", "issue": "3", "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[2018, 9, 25]]}, "abstract": "<jats:title>Abstract</jats:title>\n<jats:p><jats:italic>Toxoplasma gondii</jats:italic>, a coccidian parasite known to infect almost all warm-blooded animals, is the cause of one of the most common zoonotic parasitic diseases. The aim of the study is to determine whether the 529 bp fragment or the TGR1E gene is more useful target for PCR identification of <jats:italic>T. gondii</jats:italic>, for common use. The brains of 221 carnivores and omnivores collected between 2013 and 2015 from north-eastern Poland were examined for the presence of this parasite. The DNA was extracted and then amplified using specific primers. Positive results were obtained in 24% of brain samples using the TGR1E target and 19% using the 529 bp sequence. The results demonstrate that both TGR1E and 529 bp repeat element are suitable for detecting <jats:italic>T. gondii</jats:italic> DNA in wildlife animals, and the combination of two methods is necessary to obtain reliable results.</jats:p>", "DOI": "10.1515/ap-2018-0072", "type": "journal-article", "created": {"date-parts": [[2018, 7, 12]], "date-time": "2018-07-12T17:08:10Z", "timestamp": 1531415290000}, "page": "634-639", "source": "Crossref", "is-referenced-by-count": 1, "title": ["Comparison of sensitivity of two primer sets for the detection of Toxoplasma gondii DNA in wildlife"], "prefix": "10.1515", "volume": "63", "author": [{"given": "Aleksandra", "family": "Kornacka", "sequence": "first", "affiliation": []}, {"given": "Aleksandra", "family": "Cybulska", "sequence": "additional", "affiliation": []}, {"given": "Bo\u017cena", "family": "Moskwa", "sequence": "additional", "affiliation": []}], "member": "374", "container-title": ["Acta Parasitologica"], "link": [{"URL": "http://www.degruyter.com/view/j/ap.2018.63.issue-3/ap-2018-0072/ap-2018-0072.xml", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.degruyter.com/view/j/ap.2018.63.issue-3/ap-2018-0072/ap-2018-0072.pdf", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2018, 7, 16]], "date-time": "2018-07-16T22:17:49Z", "timestamp": 1531779469000}, "score": 23.89386, "issued": {"date-parts": [[2018, 9, 25]]}, "references-count": 0, "journal-issue": {"issue": "3"}, "URL": "http://dx.doi.org/10.1515/ap-2018-0072", "ISSN": ["1896-1851", "1230-2821"], "issn-type": [{"value": "1230-2821", "type": "print"}, {"value": "1896-1851", "type": "electronic"}], "subject": ["Parasitology"]}, {"indexed": {"date-parts": [[2019, 11, 25]], "date-time": "2019-11-25T17:39:27Z", "timestamp": 1574703567286}, "publisher-location": "Cham", "reference-count": 98, "publisher": "Springer International Publishing", "isbn-type": [{"value": "9783319141503", "type": "print"}, {"value": "9783319141510", "type": "electronic"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[2015]]}, "DOI": "10.1007/978-3-319-14151-0_9", "type": "book-chapter", "created": {"date-parts": [[2015, 6, 13]], "date-time": "2015-06-13T10:56:31Z", "timestamp": 1434192991000}, "page": "225-260", "source": "Crossref", "is-referenced-by-count": 1, "title": ["Preclinical Chemosensitization by PARP Inhibitors"], "prefix": "10.1007", "author": [{"given": "David R.", "family": "Shalinsky", "sequence": "first", "affiliation": []}, {"given": "Cherrie K.", "family": "Donawho", "sequence": "additional", "affiliation": []}, {"given": "Gerrit", "family": "Los", "sequence": "additional", "affiliation": []}, {"given": "Joann P.", "family": "Palma", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2015, 6, 14]]}, "reference": [{"issue": "10", "key": "9_CR1", "doi-asserted-by": "publisher", "first-page": "1686", "DOI": "10.1158/1541-7786.MCR-09-0299", "volume": "7", "author": "X Liu", "year": "2009", "unstructured": "Liu X, Han EK, Anderson M, Shi Y, Semizarov D, Wang G, McGonigal T, Roberts L, Lasko L, Palma J, Zhu GD, Penning T, Rosenberg S, Giranda VL, Luo Y, Leverson J, Johnson EF, Shoemaker AR (2009) Acquired resistance to combination treatment with temozolomide and ABT-888 is mediated by both base excision repair and homologous recombination DNA repair pathways. Mol Cancer Res 7(10):1686\u20131692. doi:10.1158/1541-7786.MCR-09-02991541-7786.MCR-09-0299 [pii]", "journal-title": "Mol Cancer Res"}, {"issue": "17", "key": "9_CR2", "doi-asserted-by": "publisher", "first-page": "1951", "DOI": "10.1101/gad.1331805", "volume": "19", "author": "MY Kim", "year": "2005", "unstructured": "Kim MY, Zhang T, Kraus WL (2005) Poly(ADP-ribosyl)ation by PARP-1: 'PAR-laying' NAD+ into a nuclear signal. Genes Dev 19(17):1951\u20131967. doi:19/17/1951 [pii]10.1101/gad.1331805", "journal-title": "Genes Dev"}, {"issue": "4", "key": "9_CR3", "doi-asserted-by": "publisher", "first-page": "293", "DOI": "10.1038/nrc2812", "volume": "10", "author": "M Rouleau", "year": "2010", "unstructured": "Rouleau M, Patel A, Hendzel MJ, Kaufmann SH, Poirier GG (2010) PARP inhibition: PARP1 and beyond. Nat Rev Cancer 10(4):293\u2013301. doi:10.1038/nrc2812nrc2812 [pii]", "journal-title": "Nat Rev Cancer"}, {"key": "9_CR4", "author": "Y Drew", "year": "2011", "unstructured": "Drew Y (2011) The potential of the PARP-1 inhibitor, AG014699, in human cancers defective in homologous recombination DNA repair. University of New Castle Upon Tyne, New Castle Upon Tyne", "volume-title": "The potential of the PARP-1 inhibitor, AG014699, in human cancers defective in homologous recombination DNA repair"}, {"issue": "5747", "key": "9_CR5", "doi-asserted-by": "publisher", "first-page": "593", "DOI": "10.1038/283593a0", "volume": "283", "author": "BW Durkacz", "year": "1980", "unstructured": "Durkacz BW, Omidiji O, Gray DA, Shall S (1980) (ADP-ribose)n participates in DNA excision repair. Nature 283(5747):593\u2013596", "journal-title": "Nature"}, {"issue": "12", "key": "9_CR6", "doi-asserted-by": "publisher", "first-page": "4561", "DOI": "10.1021/jm100012m", "volume": "53", "author": "DV Ferraris", "year": "2010", "unstructured": "Ferraris DV (2010) Evolution of poly(ADP-ribose) polymerase-1 (PARP-1) inhibitors. From concept to clinic. J Med Chem 53(12):4561\u20134584. doi:10.1021/jm100012m", "journal-title": "J Med Chem"}, {"issue": "6", "key": "9_CR7", "doi-asserted-by": "publisher", "first-page": "659", "DOI": "10.1080/09553008414551891", "volume": "46", "author": "E Ben-Hur", "year": "1984", "unstructured": "Ben-Hur E (1984) Involvement of poly (ADP-ribose) in the radiation response of mammalian cells. Int J Radiat Biol Relat Stud Phys Chem Med 46(6):659\u2013671", "journal-title": "Int J Radiat Biol Relat Stud Phys Chem Med"}, {"issue": "6", "key": "9_CR8", "first-page": "507", "volume": "10", "author": "RJ Griffin", "year": "1995", "unstructured": "Griffin RJ, Pemberton LC, Rhodes D, Bleasdale C, Bowman K, Calvert AH, Curtin NJ, Durkacz BW, Newell DR, Porteous JK et\u00a0al (1995) Novel potent inhibitors of the DNA repair enzyme poly(ADP-ribose)polymerase (PARP). Anticancer Drug Des 10(6):507\u2013514", "journal-title": "Anticancer Drug Des"}, {"issue": "22", "key": "9_CR9", "doi-asserted-by": "publisher", "first-page": "4084", "DOI": "10.1021/jm000950v", "volume": "43", "author": "AW White", "year": "2000", "unstructured": "White AW, Almassy R, Calvert AH, Curtin NJ, Griffin RJ, Hostomsky Z, Maegley K, Newell DR, Srinivasan S, Golding BT (2000) Resistance-modifying agents. 9. Synthesis and biological properties of benzimidazole inhibitors of the DNA repair enzyme poly(ADP-ribose) polymerase. J Med Chem 43(22):4084\u20134097", "journal-title": "J Med Chem"}, {"issue": "22", "key": "9_CR10", "doi-asserted-by": "publisher", "first-page": "5467", "DOI": "10.1021/jm030513r", "volume": "47", "author": "JG Tikhe", "year": "2004", "unstructured": "Tikhe JG, Webber SE, Hostomsky Z, Maegley KA, Ekkers A, Li J, Yu X-H, Almassy RJ, Kumpf RA, Boritzki TJ, Zhang C, Calabrese CR, Curtin NJ, Kyle S, Thomas HD, Wang L-Z, Calvert AH, Golding BT, Griffin RJ, Newell DR (2004) Design, synthesis, and evaluation of 3,4-dihydro-2H-(1,4)diazepino (6,7,1-hi)indol-1-ones as inhibitors of poly(ADP-ribose) polymerase. J Med Chem 47(22):5467\u20135481", "journal-title": "J Med Chem"}, {"issue": "4", "key": "9_CR11", "doi-asserted-by": "publisher", "first-page": "1", "DOI": "10.1017/S146239940500904X", "volume": "7", "author": "NJ Curtin", "year": "2005", "unstructured": "Curtin NJ (2005) PARP inhibitors for cancer therapy. Expert Rev Mol Med 7(4):1\u201320", "journal-title": "Expert Rev Mol Med"}, {"issue": "23", "key": "9_CR12", "doi-asserted-by": "publisher", "first-page": "7917", "DOI": "10.1158/1078-0432.CCR-08-1223", "volume": "14", "author": "R Plummer", "year": "2008", "unstructured": "Plummer R, Jones C, Middleton M, Wilson R, Evans J, Olsen A, Curtin N, Boddy A, McHugh P, Newell D, Harris A, Johnson P, Steinfeldt H, Dewji R, Wang D, Robson L, Calvert H (2008) Phase I study of the poly(ADP-ribose) polymerase inhibitor, AG014699, in combination with temozolomide in patients with advanced solid tumors. Clin Cancer Res 14(23):7917\u20137923. doi:10.1158/1078-0432.CCR-08-122314/23/7917 [pii]", "journal-title": "Clin Cancer Res"}, {"issue": "2", "key": "9_CR13", "doi-asserted-by": "publisher", "first-page": "514", "DOI": "10.1021/jm801171j", "volume": "52", "author": "TD Penning", "year": "2009", "unstructured": "Penning TD, Zhu GD, Gandhi VB, Gong J, Liu X, Shi Y, Klinghofer V, Johnson EF, Donawho CK, Frost DJ, Bontcheva-Diaz V, Bouska JJ, Osterling DJ, Olson AM, Marsh KC, Luo Y, Giranda VL (2009) Discovery of the Poly(ADP-ribose) polymerase (PARP) inhibitor 2-[(R)-2-methylpyrrolidin-2-yl]-1H-benzimidazole-4-carboxamide (ABT-888) for the treatment of cancer. J Med Chem 52(2):514\u2013523. doi:10.1021/jm801171j10.1021/jm801171j [pii]", "journal-title": "J Med Chem"}, {"issue": "20", "key": "9_CR14", "doi-asserted-by": "publisher", "first-page": "6581", "DOI": "10.1021/jm8001263", "volume": "51", "author": "KA Menear", "year": "2008", "unstructured": "Menear KA, Adcock C, Boulter R, Cockcroft XL, Copsey L, Cranston A, Dillon KJ, Drzewiecki J, Garman S, Gomez S, Javaid H, Kerrigan F, Knights C, Lau A, Loh VM Jr, Matthews IT, Moore S, O' Connor MJ, Smith GC, Martin NM (2008) 4-[3-(4-cyclopropanecarbonylpiperazine-1-carbonyl)-4-fluorobenzyl]-2H-phthalazin- 1-one: a novel bioavailable inhibitor of poly(ADP-ribose) polymerase-1. J Med Chem 51(20):6581\u20136591", "journal-title": "J Med Chem"}, {"issue": "5", "key": "9_CR15", "doi-asserted-by": "publisher", "first-page": "750", "DOI": "10.1038/bjc.2011.8", "volume": "104", "author": "OA Khan", "year": "2011", "unstructured": "Khan OA, Gore M, Lorigan P, Stone J, Greystoke A, Burke W, Carmichael J, Watson AJ, McGown G, Thorncroft M, Margison GP, Califano R, Larkin J, Wellman S, Middleton MR (2011) A phase I study of the safety and tolerability of olaparib (AZD2281, KU0059436) and dacarbazine in patients with advanced solid tumours. Br J Cancer 104(5):750\u2013755. doi:10.1038/bjc.2011.8bjc20118 [pii]", "journal-title": "Br J Cancer"}, {"issue": "25", "key": "9_CR16", "doi-asserted-by": "publisher", "first-page": "7559", "DOI": "10.1021/bi0003442", "volume": "39", "author": "F Dantzer", "year": "2000", "unstructured": "Dantzer F, de La Rubia G, Menissier-De Murcia J, Hostomsky Z, de Murcia G, Schreiber V (2000) Base excision repair is impaired in mammalian cells lacking Poly(ADP-ribose) polymerase-1. Biochemistry 39(25):7559\u20137569. doi:bi0003442 [pii]", "journal-title": "Biochemistry"}, {"issue": "2", "key": "9_CR17", "doi-asserted-by": "publisher", "first-page": "251", "DOI": "10.1002/ijc.25683", "volume": "128", "author": "A Mangerich", "year": "2011", "unstructured": "Mangerich A, Burkle A (2011) How to kill tumor cells with inhibitors of poly(ADP-ribosyl)ation. Int J Cancer J Int Du Cancer 128(2):251\u2013265. doi:10.1002/ijc.25683", "journal-title": "Int J Cancer J Int Du Cancer"}, {"key": "9_CR18", "unstructured": "de Lartigue J (2013) New life for PARP Inhibitors: emerging Agents Leave Mark at ASCO. Paper presented at the American Society of Clinical Oncology, Chicago, IL"}, {"issue": "18", "key": "9_CR19", "doi-asserted-by": "publisher", "first-page": "5003", "DOI": "10.1158/1078-0432.CCR-13-1391", "volume": "19", "author": "Y Shen", "year": "2013", "unstructured": "Shen Y, Rehman FL, Feng Y, Boshuizen J, Bajrami I, Elliott R, Wang B, Lord CJ, Post LE, Ashworth A (2013) BMN 673, a novel and highly potent PARP1/2 inhibitor for the treatment of human cancers with DNA repair deficiency. Clin Cancer Res 19(18):5003\u20135015", "journal-title": "Clin Cancer Res"}, {"issue": "6367", "key": "9_CR20", "doi-asserted-by": "publisher", "first-page": "356", "DOI": "10.1038/356356a0", "volume": "356", "author": "MS Satoh", "year": "1992", "unstructured": "Satoh MS, Lindahl T (1992) Role of poly(ADP-ribose) formation in DNA repair. Nature 356(6367):356\u2013358. doi:10.1038/356356a0", "journal-title": "Nature"}, {"issue": "2", "key": "9_CR21", "doi-asserted-by": "publisher", "first-page": "210", "DOI": "10.1021/jm0255769", "volume": "46", "author": "DJ Skalitzky", "year": "2003", "unstructured": "Skalitzky DJ, Marakovits JT, Maegley KA, Ekker A, Yu XH, Hostomsky Z, Webber SE, Eastman BW, Almassy R, Li J, Curtin NJ, Newell DR, Calvert AH, Griffin RJ, Golding BT (2003) Tricyclic benzimidazoles as potent poly(ADP-ribose) polymerase-1 inhibitors. J Med Chem 46(2):210\u2013213", "journal-title": "J Med Chem"}, {"issue": "4", "key": "9_CR22", "doi-asserted-by": "publisher", "first-page": "1", "DOI": "10.1017/S146239940500904X", "volume": "7", "author": "NJ Curtin", "year": "2005", "unstructured": "Curtin NJ (2005) PARP inhibitors for cancer therapy. Expert Rev Mol Med 7(4):1\u201320. doi:S146239940500904X [pii]10.1017/S146239940500904X", "journal-title": "Expert Rev Mol Med"}, {"key": "9_CR23", "doi-asserted-by": "crossref", "first-page": "463", "DOI": "10.1007/978-1-61779-270-0_28", "volume": "780", "author": "S Canan", "year": "2011", "unstructured": "Canan S, Maegley K, Curtin N (2011) Strategies employed for the development of PARP inhibitors. Methods Mol Biol 780:463\u2013489. doi:10.1007/978-1-61779-270-0_28", "journal-title": "Methods Mol Biol"}, {"issue": "1", "key": "9_CR24", "doi-asserted-by": "publisher", "first-page": "1", "DOI": "10.1016/S0921-8777(00)00016-1", "volume": "460", "author": "S Shall", "year": "2000", "unstructured": "Shall S, de Murcia G (2000) Poly(ADP-ribose) polymerase-1: what have we learned from the deficient mouse model? Mutat Res 460(1):1\u201315", "journal-title": "Mutat Res"}, {"issue": "8", "key": "9_CR25", "doi-asserted-by": "publisher", "first-page": "e24148", "DOI": "10.1371/journal.pone.0024148", "volume": "6", "author": "S Nowsheen", "year": "2011", "unstructured": "Nowsheen S, Bonner JA, Lobuglio AF, Trummell H, Whitley AC, Dobelbower MC, Yang ES (2011) Cetuximab augments cytotoxicity with poly (adp-ribose) polymerase inhibition in head and neck cancer. PLoS One 6(8):e24148", "journal-title": "PLoS One"}, {"issue": "3", "key": "9_CR26", "doi-asserted-by": "publisher", "first-page": "331", "DOI": "10.1016/j.radonc.2011.05.084", "volume": "99", "author": "S Nowsheen", "year": "2011", "unstructured": "Nowsheen S, Bonner JA, Yang ES (2011) The poly(ADP-Ribose) polymerase inhibitor ABT-888 reduces radiation-induced nuclear EGFR and augments head and neck tumor response to radiotherapy. Radiother Oncol 99(3):331\u2013338", "journal-title": "Radiother Oncol"}, {"issue": "9", "key": "9_CR27", "doi-asserted-by": "publisher", "first-page": "2728", "DOI": "10.1158/1078-0432.CCR-06-3039", "volume": "13", "author": "CK Donawho", "year": "2007", "unstructured": "Donawho CK, Luo Y, Penning TD, Bauch JL, Bouska JJ, Bontcheva-Diaz VD, Cox BF, DeWeese TL, Dillehay LE, Ferguson DC, Ghoreishi-Haack NS, Grimm DR, Guan R, Han EK, Holley-Shanks RR, Hristov B, Idler KB, Jarvis K, Johnson EF, Kleinberg LR, Klinghofer V, Lasko LM, Liu X, Marsh KC, McGonigal TP, Meulbroek JA, Olson AM, Palma JP, Rodriguez LE, Shi Y, Stavropoulos JA, Tsurutani AC, Zhu GD, Rosenberg SH, Giranda VL, Frost DJ (2007) ABT-888, an orally active poly(ADP-ribose) polymerase inhibitor that potentiates DNA-damaging agents in preclinical tumor models. Clin Cancer Res 13(9):2728\u20132737. doi:13/9/2728 [pii]10.1158/1078-0432.CCR-06-3039", "journal-title": "Clin Cancer Res"}, {"issue": "6", "key": "9_CR28", "doi-asserted-by": "publisher", "first-page": "1726", "DOI": "10.1158/1078-0432.CCR-11-2821", "volume": "18", "author": "S Kummar", "year": "2012", "unstructured": "Kummar S, Ji J, Morgan R, Lenz HJ, Puhalla SL, Belani CP, Gandara DR, Allen D, Kiesel B, Beumer JH, Newman EM, Rubinstein L, Chen A, Zhang Y, Wang L, Kinders RJ, Parchment RE, Tomaszewski JE, Doroshow JH (2012) A phase I study of veliparib in combination with metronomic cyclophosphamide in adults with refractory solid tumors and lymphomas. Clin Cancer Res 18(6):1726\u20131734", "journal-title": "Clin Cancer Res"}, {"issue": "24", "key": "9_CR29", "doi-asserted-by": "publisher", "first-page": "6368", "DOI": "10.1182/blood-2011-06-363911", "volume": "118", "author": "P Neri", "year": "2011", "unstructured": "Neri P, Ren L, Gratton K, Stebner E, Johnson J, Klimowicz A, Duggan P, Tassone P, Mansoor A, Stewart DA, Lonial S, Boise LH, Bahlis NJ (2011) Bortezomib-induced \u201cBRCAness\u201d sensitizes multiple myeloma cells to PARP inhibitors. Blood 118(24):6368\u20136379", "journal-title": "Blood"}, {"issue": "4", "key": "9_CR30", "doi-asserted-by": "publisher", "first-page": "767", "DOI": "10.1124/mol.112.080614", "volume": "82", "author": "AM Huehls", "year": "2012", "unstructured": "Huehls AM, Wagner JM, Huntoon CJ, Karnitz LM (2012) Identification of DNA repair pathways that affect the survival of ovarian cancer cells treated with a poly(ADP-ribose) polymerase inhibitor in a novel drug combination. Mol Pharmacol 82(4):767\u2013776", "journal-title": "Mol Pharmacol"}, {"issue": "3", "key": "9_CR31", "doi-asserted-by": "publisher", "first-page": "469", "DOI": "10.1016/j.ijrobp.2013.02.015", "volume": "86", "author": "JW Shelton", "year": "2013", "unstructured": "Shelton JW, Waxweiler TV, Landry J, Gao H, Xu Y, Wang L, El-Rayes B, Shu HK (2013) In vitro and in vivo enhancement of chemoradiation using the oral PARP inhibitor ABT-888 in colorectal cancer cells. Int J Radiat Oncol Biol Phys 86(3):469\u2013476", "journal-title": "Int J Radiat Oncol Biol Phys"}, {"issue": "2", "key": "9_CR32", "doi-asserted-by": "publisher", "first-page": "461", "DOI": "10.1007/s10637-012-9886-7", "volume": "31", "author": "D Davidson", "year": "2013", "unstructured": "Davidson D, Wang Y, Aloyz R, Panasci L (2013) The PARP inhibitor ABT-888 synergizes irinotecan treatment of colon cancer cell lines. Invest New Drugs 31(2):461\u2013468", "journal-title": "Invest New Drugs"}, {"issue": "1", "key": "9_CR33", "doi-asserted-by": "crossref", "first-page": "210", "DOI": "10.3892/ijo.2013.1932", "volume": "43", "author": "L Tentori", "year": "2013", "unstructured": "Tentori L, Leonetti C, Muzi A, Dorio AS, Porru M, Dolci S, Campolo F, Vernole P, Lacal PM, Praz F, Graziani G (2013) Influence of MLH1 on colon cancer sensitivity to poly(ADP-ribose) polymerase inhibitor combined with irinotecan. Int J Oncol 43(1):210\u2013218", "journal-title": "Int J Oncol"}, {"issue": "22", "key": "9_CR34", "doi-asserted-by": "publisher", "first-page": "6322", "DOI": "10.1158/1078-0432.CCR-13-1975", "volume": "19", "author": "RJ Cardnell", "year": "2013", "unstructured": "Cardnell RJ, Feng Y, Diao L, Fan YH, Masrorpour F, Wang J, Shen Y, Mills GB, Minna JD, Heymach JV, Byers LA (2013) Proteomic markers of DNA repair and PI3K pathway activation predict response to the PARP inhibitor BMN 673 in small cell lung cancer. Clin Cancer Res 19(22):6322\u20136328", "journal-title": "Clin Cancer Res"}, {"issue": "16", "key": "9_CR35", "doi-asserted-by": "publisher", "first-page": "7491", "DOI": "10.1073/pnas.0914242107", "volume": "107", "author": "A Kumar", "year": "2010", "unstructured": "Kumar A, Fernandez-Capetillo O, Carrera AC (2010) Nuclear phosphoinositide 3-kinase beta controls double-strand break DNA repair. Proc Natl Acad Sci U S A 107(16):7491\u20137496", "journal-title": "Proc Natl Acad Sci U S A"}, {"issue": "11", "key": "9_CR36", "doi-asserted-by": "publisher", "first-page": "1036", "DOI": "10.1158/2159-8290.CD-11-0348", "volume": "2", "author": "YH Ibrahim", "year": "2012", "unstructured": "Ibrahim YH, Garcia-Garcia C, Serra V, He L, Torres-Lockhart K, Prat A, Anton P, Cozar P, Guzman M, Grueso J, Rodriguez O, Calvo MT, Aura C, Diez O, Rubio IT, Perez J, Rodon J, Cortes J, Ellisen LW, Scaltriti M, Baselga J (2012) PI3K inhibition impairs BRCA1/2 expression and sensitizes BRCA-proficient triple-negative breast cancer to PARP inhibition. Cancer Discov 2(11):1036\u20131047", "journal-title": "Cancer Discov"}, {"issue": "11", "key": "9_CR37", "doi-asserted-by": "publisher", "first-page": "982", "DOI": "10.1158/2159-8290.CD-12-0433", "volume": "2", "author": "FL Rehman", "year": "2012", "unstructured": "Rehman FL, Lord CJ, Ashworth A (2012) The promise of combining inhibition of PI3K and PARP as cancer therapy. Cancer Discov 2(11):982\u2013984", "journal-title": "Cancer Discov"}, {"issue": "3", "key": "9_CR38", "doi-asserted-by": "publisher", "first-page": "375", "DOI": "10.1124/pr.54.3.375", "volume": "54", "author": "L Virag", "year": "2002", "unstructured": "Virag L, Szabo C (2002) The therapeutic potential of poly(ADP-Ribose) polymerase inhibitors. Pharmacol Rev 54(3):375\u2013429", "journal-title": "Pharmacol Rev"}, {"issue": "3", "key": "9_CR39", "doi-asserted-by": "publisher", "first-page": "193", "DOI": "10.1038/nrc2342", "volume": "8", "author": "T Helleday", "year": "2008", "unstructured": "Helleday T, Petermann E, Lundin C, Hodgson B, Sharma RA (2008) DNA repair pathways as targets for cancer therapy. Nat Rev Cancer 8(3):193\u2013204. doi:10.1038/nrc2342nrc2342 [pii]", "journal-title": "Nat Rev Cancer"}, {"issue": "6", "key": "9_CR40", "doi-asserted-by": "publisher", "first-page": "1775", "DOI": "10.1158/1535-7163.MCT-09-1027", "volume": "9", "author": "DA Loser", "year": "2010", "unstructured": "Loser DA, Shibata A, Shibata AK, Woodbine LJ, Jeggo PA, Chalmers AJ (2010) Sensitization to radiation and alkylating agents by inhibitors of poly(ADP-ribose) polymerase is enhanced in cells deficient in DNA double-strand break repair. Mol Cancer Ther 9(6):1775\u20131787. doi:10.1158/1535-7163.MCT-09-10271535-7163.MCT-09-1027 [pii]", "journal-title": "Mol Cancer Ther"}, {"issue": "3", "key": "9_CR41", "doi-asserted-by": "publisher", "first-page": "360", "DOI": "10.1158/1541-7786.MCR-11-0477", "volume": "10", "author": "PS Kedar", "year": "2012", "unstructured": "Kedar PS, Stefanick DF, Horton JK, Wilson SH (2012) Increased PARP-1 association with DNA in alkylation damaged, PARP-inhibited mouse fibroblasts. Mol Cancer Res 10(3):360\u2013368. doi:10.1158/1541-7786.MCR-11-0477", "journal-title": "Mol Cancer Res"}, {"issue": "21", "key": "9_CR42", "doi-asserted-by": "publisher", "first-page": "5588", "DOI": "10.1158/0008-5472.CAN-12-2753", "volume": "72", "author": "J Murai", "year": "2012", "unstructured": "Murai J, Huang SY, Das BB, Renaud A, Zhang Y, Doroshow JH, Ji J, Takeda S, Pommier Y (2012) Trapping of PARP1 and PARP2 by Clinical PARP Inhibitors. Cancer Res 72(21):5588\u20135599. doi:10.1158/0008-5472.CAN-12-2753", "journal-title": "Cancer Res"}, {"issue": "7035", "key": "9_CR43", "doi-asserted-by": "publisher", "first-page": "913", "DOI": "10.1038/nature03443", "volume": "434", "author": "E. Bryant H", "year": "2005", "unstructured": "Bryant HE., Schultz N, Thomas HD, Parker KM, Flower D, Lopez E, Kyle S, Meuth M, Curtin NJ, Helleday T (2005) Specific killing of BRCA2-deficient tumours with inhibitors of poly (ADP-ribose) polymerase. Nature 434(7035):913\u2013917", "journal-title": "Nature"}, {"issue": "7035", "key": "9_CR44", "doi-asserted-by": "publisher", "first-page": "917", "DOI": "10.1038/nature03445", "volume": "434", "author": "H Farmer", "year": "2005", "unstructured": "Farmer H, McCabe N, Lord CJ, Tutt ANJ, Johnson DA, Richardson TB, Santarosa M, Dillon KJ, Hickson I, Knights C, Martin NMB, Jackson SP, Smith GCM, Ashworth A (2005) Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy. Nature 434(7035):917\u2013921", "journal-title": "Nature"}, {"issue": "16", "key": "9_CR45", "doi-asserted-by": "publisher", "first-page": "8109", "DOI": "10.1158/0008-5472.CAN-06-0140", "volume": "66", "author": "N McCabe", "year": "2006", "unstructured": "McCabe N, Turner NC, Lord CJ, Kluzek K, Bialkowska A, Swift S, Giavara S, O' connor MJ, Tutt AN, Zdzienicka MZ, Smith GCM, Ashworth A (2006) Deficiency in the repair of DNA damage by homologous recombination and sensitivity to PolyADP-ribose polymerase inhibition. Cancer Res 66(16):8109\u20138115", "journal-title": "Cancer Res"}, {"issue": "11", "key": "9_CR46", "doi-asserted-by": "publisher", "first-page": "1048", "DOI": "10.1158/2159-8290.CD-11-0336", "volume": "2", "author": "A Juvekar", "year": "2012", "unstructured": "Juvekar A, Burga LN, Hu H, Lunsford EP, Ibrahim YH, Balmana J, Rajendran A, Papa A, Spencer K, Lyssiotis CA, Nardella C, Pandolfi PP, Baselga J, Scully R, Asara JM, Cantley LC, Wulf GM (2012) Combining a PI3K inhibitor with a PARP inhibitor provides an effective therapy for BRCA1-related breast cancer. Cancer Discov 2(11):1048\u20131063", "journal-title": "Cancer Discov"}, {"issue": "6\u20137", "key": "9_CR47", "doi-asserted-by": "publisher", "first-page": "315", "DOI": "10.1002/emmm.200900041", "volume": "1", "author": "AM Mendes-Pereira", "year": "2009", "unstructured": "Mendes-Pereira AM, Martin SA, Brough R, McCarthy A, Taylor JR, Kim JS, Waldman T, Lord CJ, Ashworth A (2009) Synthetic lethal targeting of PTEN mutant cells with PARP inhibitors. EMBO Mol Med 1(6\u20137):315\u2013322. doi:10.1002/emmm.200900041", "journal-title": "EMBO Mol Med"}, {"issue": "7", "key": "9_CR48", "doi-asserted-by": "publisher", "first-page": "875", "DOI": "10.1038/nm.2377", "volume": "17", "author": "N Johnson", "year": "2011", "unstructured": "Johnson N, Li YC, Walton ZE, Cheng KA, Li D, Rodig SJ, Moreau LA, Unitt C, Bronson RT, Thomas HD, Newell DR, D\u2019Andrea AD, Curtin NJ, Wong KK, Shapiro GI (2011) Compromised CDK1 activity sensitizes BRCA-proficient cancers to PARP inhibition. Nat Med 17(7):875\u2013882", "journal-title": "Nat Med"}, {"issue": "18", "key": "9_CR49", "doi-asserted-by": "publisher", "first-page": "4796", "DOI": "10.1158/0008-5472.CAN-12-1287", "volume": "72", "author": "S Nowsheen", "year": "2012", "unstructured": "Nowsheen S, Cooper T, Bonner JA, LoBuglio AF, Yang ES (2012) HER2 overexpression renders human breast cancers sensitive to PARP inhibition independently of any defect in homologous recombination DNA repair. Cancer Res 72(18):4796\u20134806", "journal-title": "Cancer Res"}, {"issue": "10", "key": "9_CR50", "doi-asserted-by": "publisher", "first-page": "1087", "DOI": "10.1002/emmm.201201250", "volume": "4", "author": "I Bajrami", "year": "2012", "unstructured": "Bajrami I, Kigozi A, Van Weverwijk A, Brough R, Frankum J, Lord CJ, Ashworth A (2012) Synthetic lethality of PARP and NAMPT inhibition in triple-negative breast cancer cells. EMBO Mol Med 4(10):1087\u20131096", "journal-title": "EMBO Mol Med"}, {"issue": "6", "key": "9_CR51", "doi-asserted-by": "publisher", "first-page": "1217", "DOI": "10.1016/j.mam.2013.01.006", "volume": "34", "author": "NJ Curtin", "year": "2013", "unstructured": "Curtin NJ, Szabo C (2013) Therapeutic applications of PARP inhibitors: anticancer therapy and beyond. Mol Aspects Med 34(6):1217\u20131256", "journal-title": "Mol Aspects Med"}, {"key": "9_CR52", "doi-asserted-by": "publisher", "first-page": "136", "DOI": "10.1196/annals.1414.020", "volume": "1138", "author": "Y Drew", "year": "2008", "unstructured": "Drew Y, Calvert H (2008) The potential of PARP inhibitors in genetic breast and ovarian cancers. Ann N Y Acad Sci 1138:136\u2013145. doi:10.1196/annals.1414.020NYAS1138020 [pii]", "journal-title": "Ann N Y Acad Sci"}, {"issue": "2", "key": "9_CR53", "doi-asserted-by": "publisher", "first-page": "123", "DOI": "10.1056/NEJMoa0900212", "volume": "361", "author": "PC Fong", "year": "2009", "unstructured": "Fong PC, Boss DS, Yap TA, Tutt A, Wu P, Mergui-Roelvink M, Mortimer P, Swaisland H, Lau A, O' Connor MJ, Ashworth A, Carmichael J, Kaye SB, Schellens JH, de Bono JS (2009) Inhibition of poly(ADP-ribose) polymerase in tumors from BRCA mutation carriers. N Engl J Med 361(2):123\u2013134", "journal-title": "N Engl J Med"}, {"issue": "2", "key": "9_CR54", "doi-asserted-by": "publisher", "first-page": "268", "DOI": "10.1093/annonc/mdq322", "volume": "22", "author": "C Underhill", "year": "2011", "unstructured": "Underhill C, Toulmonde M, Bonnefoi H (2011) A review of PARP inhibitors: from bench to bedside. Ann Oncol 22(2):268\u2013279. doi:10.1093/annonc/mdq322mdq322 [pii]", "journal-title": "Ann Oncol"}, {"issue": "3", "key": "9_CR55", "doi-asserted-by": "publisher", "first-page": "945", "DOI": "10.1158/1535-7163.MCT-06-0552", "volume": "6", "author": "HD Thomas", "year": "2007", "unstructured": "Thomas HD, Calabrese CR, Batey MA, Canan S, Hostomsky Z, Kyle S, Maegley KA, Newell DR, Skalitzky D, Wang LZ, Webber SE, Curtin NJ (2007) Preclinical selection of a novel poly(ADP-ribose) polymerase inhibitor for clinical trial. Mol Cancer Ther 6(3):945\u2013956", "journal-title": "Mol Cancer Ther"}, {"issue": "22", "key": "9_CR56", "doi-asserted-by": "publisher", "first-page": "7170", "DOI": "10.1021/jm901188v", "volume": "52", "author": "P Jones", "year": "2009", "unstructured": "Jones P, Altamura S, Boueres J, Ferrigno F, Fonsi M, Giomini C, Lamartina S, Monteagudo E, Ontoria JM, Orsale MV, Palumbi MC, Pesci S, Roscilli G, Scarpelli R, Schultz-Fademrecht C, Toniatti C, Rowley M (2009) Discovery of 2-{4-[(3S)-piperidin-3-yl]phenyl}-2H-indazole-7-carboxamide (MK-4827): a novel oral poly(ADP-ribose)polymerase (PARP) inhibitor efficacious in BRCA-1 and -2 mutant tumors. J Med Chem 52(22):7170\u20137185", "journal-title": "J Med Chem"}, {"issue": "10", "key": "9_CR57", "first-page": "1621", "volume": "6", "author": "X Liu", "year": "2008", "unstructured": "Liu X, Shi Y, Guan R, Donawho C, Luo Y, Palma J, Zhu GD, Johnson EF, Rodriguez LE, Ghoreishi-Haack N, Jarvis K, Hradil VP, Colon-Lopez M, Cox BF, Klinghofer V, Penning T, Rosenberg SH, Frost D, Giranda VL (2008) Potentiation of temozolomide cytotoxicity by poly(ADP)ribose polymerase inhibitor ABT-888 requires a conversion of single-stranded DNA damages to double-stranded DNA breaks. Mol Cancer Res 6(10):1621\u20131629. doi:10.1158/1541-7786.MCR-08-02406/10/1621 [pii]", "journal-title": "Mol Cancer Res"}, {"issue": "5A", "key": "9_CR58", "first-page": "2625", "volume": "28", "author": "JP Palma", "year": "2008", "unstructured": "Palma JP, Rodriguez LE, Bontcheva-Diaz VD, Bouska JJ, Bukofzer G, Colon-Lopez M, Guan R, Jarvis K, Johnson EF, Klinghofer V, Liu X, Olson A, Saltarelli MJ, Shi Y, Stavropoulos JA, Zhu GD, Penning TD, Luo Y, Giranda VL, Rosenberg SH, Frost DJ, Donawho CK (2008) The PARP inhibitor, ABT-888 potentiates temozolomide: correlation with drug levels and reduction in PARP activity in vivo. Anticancer Res 28(5A):2625\u20132635", "journal-title": "Anticancer Res"}, {"issue": "6", "key": "9_CR59", "doi-asserted-by": "publisher", "first-page": "934", "DOI": "10.4161/cbt.7.6.5933", "volume": "7", "author": "X Liu", "year": "2008", "unstructured": "Liu X, Luo X, Shi Y, Zhu GD, Penning T, Giranda VL, Luo Y (2008) Poly (ADP-ribose) polymerase activity regulates apoptosis in HeLa cells after alkylating DNA damage. Cancer Biol Ther 7(6):934\u2013941. doi:5933 [pii]", "journal-title": "Cancer Biol Ther"}, {"issue": "2", "key": "9_CR60", "doi-asserted-by": "publisher", "first-page": "240", "DOI": "10.1016/j.ab.2008.07.007", "volume": "381", "author": "X Liu", "year": "2008", "unstructured": "Liu X, Palma J, Kinders R, Shi Y, Donawho C, Ellis PA, Rodriguez LE, Colon-Lopez M, Saltarelli M, LeBlond D, Lin CT, Frost DJ, Luo Y, Giranda VL (2008) An enzyme-linked immunosorbent poly(ADP-ribose) polymerase biomarker assay for clinical trials of PARP inhibitors. Anal Biochem 381(2):240\u2013247. doi:10.1016/j.ab.2008.07.007S0003-2697(08)00460-0 [pii]", "journal-title": "Anal Biochem"}, {"issue": "23", "key": "9_CR61", "doi-asserted-by": "publisher", "first-page": "7277", "DOI": "10.1158/1078-0432.CCR-09-1245", "volume": "15", "author": "JP Palma", "year": "2009", "unstructured": "Palma JP, Wang YC, Rodriguez LE, Montgomery D, Ellis PA, Bukofzer G, Niquette A, Liu X, Shi Y, Lasko L, Zhu GD, Penning TD, Giranda VL, Rosenberg SH, Frost DJ, Donawho CK (2009) ABT-888 confers broad in vivo activity in combination with temozolomide in diverse tumors. Clin Cancer Res 15(23):7277\u20137290. doi:10.1158/1078-0432.CCR-09-12451078-0432.CCR-09-1245 [pii]", "journal-title": "Clin Cancer Res"}, {"key": "9_CR62", "unstructured": "Donawho C, Rodriguez LE, Ellis PA, Kaleta L, Bukofzer L, Bontcheva-Diaz V, Liu X, Bouska J, Carr R, Idler K, Zhu Z, Penning T, Shoemaker AR, Giranda VL, Buchanan FG, Frost DJ, Palma, JP (2011) Single agent in vivo activity of the PARP inhibitor, Veliparib (ABT-888) in BRCA deficient Xenografts (MX-1 and Capan-1) and combination therapies In: AACR-EORTC 2011, Molecular Targets and Cancer Therapeutics, San Francisco, CA", "DOI": "10.1158/1535-7163.TARG-11-B62", "doi-asserted-by": "crossref"}, {"key": "9_CR63", "unstructured": "Henry MD, Wen S, Silva MD, Chandra S, Milton M, Worland PJ (2004) A prostate-specific membrane antigen-targeted monoclonal antibody-chemotherapeutic conjugate designed for the treatment of prostate cancer. Cancer Res 64 (21):7995\u20138001. doi:10.1158/0008-5472.CAN-04-1722", "DOI": "10.1158/0008-5472.CAN-04-1722", "doi-asserted-by": "crossref"}, {"issue": "4", "key": "9_CR64", "doi-asserted-by": "publisher", "first-page": "364", "DOI": "10.1016/j.coph.2006.02.004", "volume": "6", "author": "ER Plummer", "year": "2006", "unstructured": "Plummer ER (2006) Inhibition of poly(ADP-ribose) polymerase in cancer. Curr Opin Pharmacol 6(4):364\u2013368. doi:S1471-4892(06)00084-1 [pii]10.1016/j.coph.2006.02.004", "journal-title": "Curr Opin Pharmacol"}, {"issue": "16", "key": "9_CR65", "doi-asserted-by": "publisher", "first-page": "2705", "DOI": "10.1200/JCO.2008.19.7681", "volume": "27", "author": "S Kummar", "year": "2009", "unstructured": "Kummar S, Kinders R, Gutierrez ME, Rubinstein L, Parchment RE, Phillips LR, Ji J, Monks A, Low JA, Chen A, Murgo AJ, Collins J, Steinberg SM, Eliopoulos H, Giranda VL, Gordon G, Helman L, Wiltrout R, Tomaszewski JE, Doroshow JH (2009) Phase 0 clinical trial of the poly (ADP-ribose) polymerase inhibitor ABT-888 in patients with advanced malignancies. J Clin Oncol 27(16):2705\u20132711. doi:10.1200/JCO.2008.19.7681JCO.2008.19.7681 [pii]", "journal-title": "J Clin Oncol"}, {"issue": "1", "key": "9_CR66", "doi-asserted-by": "publisher", "first-page": "56", "DOI": "10.1093/jnci/djh005", "volume": "96", "author": "CR Calabrese", "year": "2004", "unstructured": "Calabrese CR, Almassy R, Barton S, Batey MA, Calvert AH, Canan K, Stacie DBW, Hostomsky Z, Kumpf RA, Kyle S, Li J, Maegley K, Newell DR, Notarianni E, Stratford IJ, Skalitzky D, Thomas HD, Wang L, Zhen WSE, Williams KJ, Curtin NJ (2004) Anticancer chemosensitization and radiosensitization by the novel poly (ADP-ribose) polymerase-1 inhibitor AG14361. J Natl Cancer Inst 96(1):56\u201367", "journal-title": "J Natl Cancer Inst"}, {"issue": "4", "key": "9_CR67", "doi-asserted-by": "publisher", "first-page": "378", "DOI": "10.1016/j.urolonc.2007.02.013", "volume": "26", "author": "CA Thomas", "year": "2008", "unstructured": "Thomas CA, Grant SG, Pflug BR, Getzenberg RH, Day BW (2008) (Z)-1,1-Dichloro-2-(4-methoxyphenyl)-3-phenylcyclopropane induces concentration-dependent growth inhibition, apoptosis, and coordinates regulation of apoptotic genes in TRAMP cells. Urol Oncol 26(4):378\u2013385", "journal-title": "Urol Oncol"}, {"issue": "3", "key": "9_CR68", "doi-asserted-by": "publisher", "first-page": "881", "DOI": "10.1158/1078-0432.CCR-1144-3", "volume": "10", "author": "NJ Curtin", "year": "2004", "unstructured": "Curtin NJ, Wang LZ, Yiakouvaki A, Kyle S, Arris CA, Canan K, Stacie WSE, Durkacz BW, Calvert HA, Hostomsky Z, Newell DR (2004) Novel poly(ADP-ribose) polymerase-1 inhibitor, AG14361, restores sensitivity to temozolomide in mismatch repair-deficient cells. Clin Cancer Res 10(3):881\u2013889", "journal-title": "Clin Cancer Res"}, {"issue": "23", "key": "9_CR69", "doi-asserted-by": "publisher", "first-page": "8449", "DOI": "10.1158/1078-0432.CCR-05-1224", "volume": "11", "author": "LM Smith", "year": "2005", "unstructured": "Smith LM, Willmore E, Austin CA, Curtin NJ (2005) The novel poly(ADP-Ribose) polymerase inhibitor, AG14361, sensitizes cells to topoisomerase I poisons by increasing the persistence of DNA strand breaks. Clin Cancer Res 11(23):8449\u20138457", "journal-title": "Clin Cancer Res"}, {"issue": "4", "key": "9_CR70", "doi-asserted-by": "publisher", "first-page": "1241", "DOI": "10.1158/1078-0432.CCR-08-1095", "volume": "15", "author": "RA Daniel", "year": "2009", "unstructured": "Daniel RA, Rozanska AL, Thomas HD, Mulligan EA, Drew Y, Castelbuono DJ, Hostomsky Z, Plummer ER, Boddy AV, Tweddle DA, Curtin NJ, Clifford SC (2009) Inhibition of poly(ADP-ribose) polymerase-1 enhances temozolomide and topotecan activity against childhood neuroblastoma. Clin Cancer Res 15(4):1241\u20131249", "journal-title": "Clin Cancer Res"}, {"issue": "19", "key": "9_CR71", "doi-asserted-by": "publisher", "first-page": "6106", "DOI": "10.1158/1078-0432.CCR-09-0398", "volume": "15", "author": "M Ali", "year": "2009", "unstructured": "Ali M, Telfer BA, McCrudden C, O\u2019Rourke M, Thomas HD, Kamjoo M, Kyle S, Robson T, Shaw C, Hirst DG, Curtin NJ, Williams KJ (2009) Vasoactivity of AG014699, a clinically active small molecule inhibitor of poly(ADP-ribose) polymerase: a contributory factor to chemopotentiation in vivo? Clin Cancer Res 15(19):6106\u20136112", "journal-title": "Clin Cancer Res"}, {"issue": "12", "key": "9_CR72", "doi-asserted-by": "publisher", "first-page": "2320", "DOI": "10.1158/1535-7163.MCT-11-0356", "volume": "10", "author": "M Ali", "year": "2011", "unstructured": "Ali M, Kamjoo M, Thomas HD, Kyle S, Pavlovska I, Babur M, Telfer BA, Curtin NJ, Williams KJ (2011) The clinically active PARP inhibitor AG014699 ameliorates cardiotoxicity but does not enhance the efficacy of doxorubicin, despite improving tumor perfusion and radiation response in mice. Mol Cancer Ther 10(12):2320\u20132329. doi:10.1158/1535-7163.MCT-11-03561535-7163.MCT-11-0356 [pii]", "journal-title": "Mol Cancer Ther"}, {"issue": "12", "key": "9_CR73", "doi-asserted-by": "publisher", "first-page": "3916", "DOI": "10.1158/1078-0432.CCR-07-4953", "volume": "14", "author": "B Evers", "year": "2008", "unstructured": "Evers B, Drost R, Schut E, de Bruin M, van der Burg E, Derksen PW, Holstege H, Liu X, van Drunen E, Beverloo HB, Smith GC, Martin NM, Lau A, O\u2019Connor MJ, Jonkers J (2008) Selective inhibition of BRCA2-deficient mammary tumor cell growth by AZD2281 and cisplatin. Clin Cancer Res 14(12):3916\u20133925", "journal-title": "Clin Cancer Res"}, {"issue": "44", "key": "9_CR74", "doi-asserted-by": "publisher", "first-page": "17079", "DOI": "10.1073/pnas.0806092105", "volume": "105", "author": "S Rottenberg", "year": "2008", "unstructured": "Rottenberg S, Jaspers JE, Kersbergen A, van der Burg E, Nygren AO, Zander SA, Derksen PW, de Bruin M, Zevenhoven J, Lau A, Boulter R, Cranston A, O\u2019Connor MJ, Martin NM, Borst P, Jonkers J (2008) High sensitivity of BRCA1-deficient mammary tumors to the PARP inhibitor AZD2281 alone and in combination with platinum drugs. Proc Natl Acad Sci U S A 105(44):17079\u201317084", "journal-title": "Proc Natl Acad Sci U S A"}, {"issue": "1", "key": "9_CR75", "doi-asserted-by": "publisher", "first-page": "145", "DOI": "10.1002/pbc.24697", "volume": "61", "author": "RE Norris", "year": "2014", "unstructured": "Norris RE, Adamson PC, Nguyen VT, Fox E (2014) Preclinical evaluation of the PARP inhibitor, olaparib, in combination with cytotoxic chemotherapy in pediatric solid tumors. Pediatr Blood Cancer 61(1):145\u2013150", "journal-title": "Pediatr Blood Cancer"}, {"issue": "4", "key": "9_CR76", "first-page": "303", "volume": "16", "author": "DR Shalinsky", "year": "1998", "unstructured": "Shalinsky DR, Brekken J, Zou H, Kolis S, Wood A, Webber S, Appelt K (1998) Antitumor efficacy of AG3340 associated with maintenance of minimum effective plasma concentrations and not total daily dose, exposure or peak plasma concentrations. Invest New Drugs 16(4):303\u2013313", "journal-title": "Invest New Drugs"}, {"issue": "7", "key": "9_CR77", "first-page": "1905", "volume": "5", "author": "DR Shalinsky", "year": "1999", "unstructured": "Shalinsky DR, Brekken J, Zou H, Bloom LA, McDermott CD, Zook S, Varki NM, Appelt K (1999) Marked antiangiogenic and antitumor efficacy of AG3340 in chemoresistant human non-small cell lung cancer tumors: single agent and combination chemotherapy studies. Clin Cancer Res 5(7):1905\u20131917", "journal-title": "Clin Cancer Res"}, {"issue": "1", "key": "9_CR78", "doi-asserted-by": "publisher", "first-page": "12", "DOI": "10.1093/annonc/mdf093", "volume": "13", "author": "RS Kerbel", "year": "2002", "unstructured": "Kerbel RS, Klement G, Pritchard KI, Kamen B (2002) Continuous low-dose anti-angiogenic/metronomic chemotherapy: from the research laboratory into the oncology clinic. Ann Oncol 13(1):12\u201315", "journal-title": "Ann Oncol"}, {"issue": "6", "key": "9_CR79", "doi-asserted-by": "publisher", "first-page": "2113", "DOI": "10.1007/s10637-011-9770-x", "volume": "30", "author": "L Wang", "year": "2011", "unstructured": "Wang L, Mason KA, Ang KK, Buchholz T, Valdecanas D, Mathur A, Buser-Doepner C, Toniatti C, Milas L (2011) MK-4827, a PARP-1/-2 inhibitor, strongly enhances response of human lung and breast cancer xenografts to radiation. Invest New Drugs 30(6):2113\u20132120", "journal-title": "Invest New Drugs"}, {"issue": "3", "key": "9_CR80", "first-page": "755", "volume": "33", "author": "S Mueller", "year": "2013", "unstructured": "Mueller S, Bhargava S, Molinaro AM, Yang X, Kolkowitz I, Olow A, Wehmeijer N, Orbach S, Chen J, Matthay KK, Haas-Kogan DA (2013) Poly (ADP-Ribose) polymerase inhibitor MK-4827 together with radiation as a novel therapy for metastatic neuroblastoma. Anticancer Res 33(3):755\u2013762", "journal-title": "Anticancer Res"}, {"issue": "2", "key": "9_CR81", "doi-asserted-by": "publisher", "first-page": "649", "DOI": "10.1007/s10549-012-2106-5", "volume": "134", "author": "HC Chuang", "year": "2012", "unstructured": "Chuang HC, Kapuriya N, Kulp SK, Chen CS, Shapiro CL (2012) Differential anti-proliferative activities of poly(ADP-ribose) polymerase (PARP) inhibitors in triple-negative breast cancer cells. Breast Cancer Res Treat 134(2):649\u2013659", "journal-title": "Breast Cancer Res Treat"}, {"key": "9_CR82", "unstructured": "Maegley K, Bingham, PJ, Tatlock, J, Isaacson J, Thomas HD, Curtin NJ, Guicheri OM (2010) An in vitro Mechanistic Comparison of Clinical PARP Inhibitors. Paper presented at the PARP2010, the 18th International Conference on ADP-ribosylation, Zurich, Switzerland"}, {"issue": "2", "key": "9_CR83", "doi-asserted-by": "publisher", "first-page": "510", "DOI": "10.1158/1078-0432.CCR-11-1973", "volume": "18", "author": "X Liu", "year": "2012", "unstructured": "Liu X, Shi Y, Maag DX, Palma JP, Patterson MJ, Ellis PA, Surber BW, Ready DB, Soni NB, Ladror US, Xu AJ, Iyer R, Harlan JE, Solomon LR, Donawho CK, Penning TD, Johnson EF, Shoemaker AR (2012) Iniparib nonselectively modifies cysteine-containing proteins in tumor cells and is not a bonafide PARP inhibitor. Clin Cancer Res 18(2):510\u2013523", "journal-title": "Clin Cancer Res"}, {"issue": "6", "key": "9_CR84", "doi-asserted-by": "publisher", "first-page": "1655", "DOI": "10.1158/1078-0432.CCR-11-2890", "volume": "18", "author": "AG Patel", "year": "2012", "unstructured": "Patel AG, De Lorenzo SB, Flatten KS, Poirier GG, Kaufmann SH (2012) Failure of iniparib to inhibit poly(ADP-Ribose) polymerase in vitro. Clin Cancer Res 18(6):1655\u20131662. doi:10.1158/1078-0432.CCR-11-28901078-0432.CCR-11-2890 [pii]", "journal-title": "Clin Cancer Res"}, {"key": "9_CR85", "unstructured": "Murai J, Huang SY, Renaud A, Zhang Y, Ji J, Takeda S, Morris J, Teicher B, Doroshow JH, Pommier Y (2014) Stereospecific PARP Trapping by BMN 673 and Comparison with Olaparib and Rucaparib. Mol Cancer Ther 13(2):433\u201343. doi:10.1158/1535-7163.MCT-13-0803. Epub 2013 Dec 19", "DOI": "10.1158/1535-7163.MCT-13-0803", "doi-asserted-by": "crossref"}, {"issue": "3", "key": "9_CR86", "doi-asserted-by": "publisher", "first-page": "455", "DOI": "10.1016/S0006-2952(01)00872-3", "volume": "63", "author": "PI Bauer", "year": "2002", "unstructured": "Bauer PI, Mendeleyeva J, Kirsten E, Comstock JA, Hakam A, Buki KG, Kun E (2002) Anti-cancer action of 4-iodo-3-nitrobenzamide in combination with buthionine sulfoximine: inactivation of poly(ADP-ribose) polymerase and tumor glycolysis and the appearance of a poly(ADP-ribose) polymerase protease. Biochem Pharmacol 63(3):455\u2013462", "journal-title": "Biochem Pharmacol"}, {"key": "9_CR87", "doi-asserted-by": "publisher", "first-page": "113", "DOI": "10.3389/fonc.2013.00113", "volume": "3", "author": "E Mladenov", "year": "2013", "unstructured": "Mladenov E, Magin S, Soni A, Iliakis G (2013) DNA double-strand break repair as determinant of cellular radiosensitivity to killing and target in radiation therapy. Front Oncol 3:113. doi:10.3389/fonc.2013.00113", "journal-title": "Front Oncol"}, {"key": "9_CR88", "doi-asserted-by": "publisher", "first-page": "65", "DOI": "10.1186/1748-717X-8-65", "volume": "8", "author": "L Barazzuol", "year": "2013", "unstructured": "Barazzuol L, Jena R, Burnet NG, Meira LB, Jeynes JC, Kirkby KJ, Kirkby NF (2013) Evaluation of poly (ADP-ribose) polymerase inhibitor ABT-888 combined with radiotherapy and temozolomide in glioblastoma. Radiat Oncol 8:65. doi:10.1186/1748-717X-8-651748-717X-8-65 [pii]", "journal-title": "Radiat Oncol"}, {"issue": "2", "key": "9_CR89", "doi-asserted-by": "publisher", "first-page": "251", "DOI": "10.1038/onc.2011.229", "volume": "31", "author": "JE Hunter", "year": "2012", "unstructured": "Hunter JE, Willmore E, Irving JA, Hostomsky Z, Veuger SJ, Durkacz BW (2012) NF-kappaB mediates radio-sensitization by the PARP-1 inhibitor, AG-014699. Oncogene 31(2):251\u2013264. doi:10.1038/onc.2011.229onc2011229 [pii]", "journal-title": "Oncogene"}, {"issue": "4", "key": "9_CR90", "doi-asserted-by": "publisher", "first-page": "e60408", "DOI": "10.1371/journal.pone.0060408", "volume": "8", "author": "P Chatterjee", "year": "2013", "unstructured": "Chatterjee P, Choudhary GS, Sharma A, Singh K, Heston WD, Ciezki J, Klein EA, Almasan A (2013) PARP inhibition sensitizes to low dose-rate radiation TMPRSS2-ERG fusion gene-expressing and PTEN-deficient prostate cancer cells. PLoS One 8(4):e60408. doi:10.1371/journal.pone.0060408PONE-D-12-33768 [pii]", "journal-title": "PLoS One"}, {"issue": "4", "key": "9_CR91", "doi-asserted-by": "publisher", "first-page": "1188", "DOI": "10.1016/j.ijrobp.2008.07.031", "volume": "72", "author": "FA Dungey", "year": "2008", "unstructured": "Dungey FA, Loser DA, Chalmers AJ (2008) Replication-dependent radiosensitization of human glioma cells by inhibition of poly(ADP-Ribose) polymerase: mechanisms and therapeutic potential. Int J Radiat Oncol Biol Phys 72(4):1188\u20131197. doi:10.1016/j.ijrobp.2008.07.031S0360-3016(08)03170-2 [pii]", "journal-title": "Int J Radiat Oncol Biol Phys"}, {"issue": "24", "key": "9_CR92", "doi-asserted-by": "publisher", "first-page": "4321", "DOI": "10.4161/cc.10.24.18661", "volume": "10", "author": "S Vance", "year": "2011", "unstructured": "Vance S, Liu E, Zhao L, Parsels JD, Parsels LA, Brown JL, Maybaum J, Lawrence TS, Morgan MA (2011) Selective radiosensitization of p53 mutant pancreatic cancer cells by combined inhibition of Chk1 and PARP1. Cell Cycle 10(24):4321\u20134329. doi:10.4161/cc.10.24.1866118661 [pii]", "journal-title": "Cell Cycle"}, {"issue": "11", "key": "9_CR93", "doi-asserted-by": "publisher", "first-page": "2517", "DOI": "10.1158/1535-7163.MCT-13-0010", "volume": "12", "author": "JP Chow", "year": "2013", "unstructured": "Chow JP, Man WY, Mao M, Chen H, Cheung F, Nicholls J, Tsao SW, Li Lung M, Poon RY (2013) PARP1 is overexpressed in nasopharyngeal carcinoma and its inhibition enhances radiotherapy. Mol Cancer Ther 12(11):2517\u20132528. doi:10.1158/1535-7163.MCT-13-00101535-7163.MCT-13-0010 [pii]", "journal-title": "Mol Cancer Ther"}, {"issue": "6", "key": "9_CR94", "doi-asserted-by": "publisher", "first-page": "2113", "DOI": "10.1007/s10637-011-9770-x", "volume": "30", "author": "L Wang", "year": "2012", "unstructured": "Wang L, Mason KA, Ang KK, Buchholz T, Valdecanas D, Mathur A, Buser-Doepner C, Toniatti C, Milas L (2012) MK-4827, a PARP-1/-2 inhibitor, strongly enhances response of human lung and breast cancer xenografts to radiation. Invest New Drugs 30(6):2113\u20132120. doi:10.1007/s10637\u2013011-9770-x", "journal-title": "Invest New Drugs"}, {"issue": "17", "key": "9_CR95", "doi-asserted-by": "publisher", "first-page": "3695", "DOI": "10.1016/S0968-0896(03)00333-X", "volume": "11", "author": "D Ferraris", "year": "2003", "unstructured": "Ferraris D, Ficco Rica P, Dain D, Ginski M, Lautar S, Lee Wisdom K, Liang S, Lin Q, Lu May XC, Morgan L, Thomas B, Williams Lawrence R, Zhang J, Zhou Y, Kalish- Vincent J (2003) Design and synthesis of poly(ADP-ribose) polymerase-1 (PARP-1) inhibitors. Part 4: biological evaluation of imidazobenzodiazepines as potent PARP-1 inhibitors for treatment of ischemic injuries. Bioorg Med Chem, {Bioorg Med Chem} 11(17):3695\u20133707", "journal-title": "Bioorg Med Chem, {Bioorg Med Chem}"}, {"issue": "8", "key": "9_CR96", "doi-asserted-by": "publisher", "first-page": "2344", "DOI": "10.1158/1078-0432.CCR-09-2758", "volume": "16", "author": "A Mukhopadhyay", "year": "2010", "unstructured": "Mukhopadhyay A, Elattar A, Cerbinskaite A, Wilkinson SJ, Drew Y, Kyle S, Los G, Hostomsky Z, Edmondson RJ, Curtin NJ (2010) Development of a functional assay for homologous recombination status in primary cultures of epithelial ovarian tumor and correlation with sensitivity to poly(ADP-ribose) polymerase inhibitors. Clin Cancer Res 16(8):2344\u20132351. doi:10.1158/1078-0432.CCR-09-27581078-0432.CCR-09-2758 [pii]", "journal-title": "Clin Cancer Res"}, {"key": "9_CR97", "doi-asserted-by": "crossref", "first-page": "3361", "DOI": "10.1038/ncomms4361", "volume": "5", "author": "G Peng", "year": "2014", "unstructured": "Peng G, Chun-Jen Lin C, Mo W, Dai H, Park YY, Kim SM, Peng Y, Mo Q, Siwko S, Hu R, Lee JS, Hennessy B, Hanash S, Mills GB, Lin SY (2014) Genome-wide transcriptome profiling of homologous recombination DNA repair. Nat Commun 5:3361. doi:10.1038/ncomms4361", "journal-title": "Nat Commun"}, {"issue": "3", "key": "9_CR98", "doi-asserted-by": "publisher", "first-page": "671", "DOI": "10.1042/BJ20101723", "volume": "436", "author": "T Zaremba", "year": "2011", "unstructured": "Zaremba T, Thomas HD, Cole M, Coulthard SA, Plummer ER, Curtin NJ (2011) Poly(ADP-ribose) polymerase-1 (PARP-1) pharmacogenetics, activity and expression analysis in cancer patients and healthy volunteers. Biochem J 436(3):671\u2013679. doi:10.1042/BJ20101723BJ20101723 [pii]", "journal-title": "Biochem J"}], "container-title": ["Cancer Drug Discovery and Development", "PARP Inhibitors for Cancer Therapy"], "link": [{"URL": "http://link.springer.com/content/pdf/10.1007/978-3-319-14151-0_9", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 5, 30]], "date-time": "2019-05-30T05:37:52Z", "timestamp": 1559194672000}, "score": 23.301872, "issued": {"date-parts": [[2015]]}, "ISBN": ["9783319141503", "9783319141510"], "references-count": 98, "URL": "http://dx.doi.org/10.1007/978-3-319-14151-0_9", "relation": {"cites": []}, "ISSN": ["2196-9906", "2196-9914"], "issn-type": [{"value": "2196-9906", "type": "print"}, {"value": "2196-9914", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 19]], "date-time": "2019-11-19T01:48:56Z", "timestamp": 1574128136620}, "reference-count": 0, "publisher": "Elsevier BV", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2004, 5, 1]], "date-time": "2004-05-01T00:00:00Z", "timestamp": 1083369600000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["DNA Repair"], "published-print": {"date-parts": [[2004, 5]]}, "DOI": "10.1016/s1568-7864(04)00120-x", "type": "journal-article", "created": {"date-parts": [[2004, 5, 27]], "date-time": "2004-05-27T07:54:28Z", "timestamp": 1085644468000}, "source": "Crossref", "is-referenced-by-count": 0, "title": ["Relevance and irrelevance of DNA damage response to radiotherapy"], "prefix": "10.1016", "author": [{"given": "P", "family": "CONNELL", "sequence": "first", "affiliation": []}], "member": "78", "container-title": ["DNA Repair"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S1568-7864(04)00120-X?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S1568-7864(04)00120-X?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 2, 7]], "date-time": "2019-02-07T18:54:07Z", "timestamp": 1549565647000}, "score": 23.291763, "issued": {"date-parts": [[2004, 5]]}, "references-count": 0, "alternative-id": ["S1568-7864(04)00120-X"], "URL": "http://dx.doi.org/10.1016/s1568-7864(04)00120-x", "ISSN": ["1568-7864"], "issn-type": [{"value": "1568-7864", "type": "print"}]}], "items-per-page": 20, "query": {"start-index": 0, "search-terms": null}}}